Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:tacrolimus (anhydrous)
go back to main search page
Accession:CHEBI:61049 term browser browse the term
Definition:A macrolide lactam containing a 23-membered lactone ring, originally isolated from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis.
Synonyms:exact_synonym: (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
 related_synonym: 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN;   FK 506;   FK506;   Formula=C44H69NO12;   InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1;   InChIKey=QJJXYPPXXYFBGM-LFZNUXCKSA-N;   Prograf;   SMILES=CO[C@@H]1C[C@@H](CC[C@H]1O)\\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@H]([C@H](C[C@@H](C)C\\C(C)=C\\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC)[C@H](C[C@H]2C)OC;   Tacrolimus
 alt_id: CHEBI:42555;   CHEBI:4958
 xref: CAS:104987-11-3;   DrugBank:DB00864;   KEGG:C01375;   KEGG:D08556;   LIPID_MAPS_instance:LMPK04000003;   PDBeChem:FK5;   Patent:EP184162;   Patent:US5665727;   Reaxys:3647477;   Reaxys:8821611


Please select species to view GViewer data.

show annotations for term's descendants           Sort by:
tacrolimus (anhydrous) term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G R Cxcr4 C-X-C motif chemokine receptor 4 decreases expression
increases expression
EXP tacrolimus co-treated with plerixafor decreases expression of CXCR4 protein in liver
tacrolimus increases expression of CXCR4 protein in liver
RGD PMID:24912495 PMID:24912495 RGD:151893463, RGD:151893463 NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
JBrowse link
G M Cxcr4 chemokine (C-X-C motif) receptor 4 decreases expression
increases expression
ISO tacrolimus co-treated with plerixafor decreases expression of CXCR4 protein in liver
tacrolimus increases expression of CXCR4 protein in liver
RGD PMID:24912495 PMID:24912495 RGD:151893463, RGD:151893463 NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
JBrowse link
G H CXCR4 C-X-C motif chemokine receptor 4 decreases expression
increases expression
ISO tacrolimus co-treated with plerixafor decreases expression of CXCR4 protein in liver
tacrolimus increases expression of CXCR4 protein in liver
RGD PMID:24912495 PMID:24912495 RGD:151893463, RGD:151893463 NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
JBrowse link
tacrolimus hydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G R A2m alpha-2-macroglobulin increases expression EXP Tacrolimus results in increased expression of A2M mRNA CTD PMID:21865292 NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
JBrowse link
G M A2m alpha-2-macroglobulin increases expression ISO Tacrolimus results in increased expression of A2M mRNA CTD PMID:21865292 NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
JBrowse link
G H A2M alpha-2-macroglobulin increases expression ISO Tacrolimus results in increased expression of A2M mRNA CTD PMID:21865292 NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
JBrowse link
G R Abca1 ATP binding cassette subfamily A member 1 multiple interactions
increases expression
ISO
EXP
[Sirolimus co-treated with Tacrolimus] results in increased expression of ABCA1 protein
Tacrolimus results in increased expression of ABCA1 mRNA
CTD PMID:17016853 PMID:21865292 NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
JBrowse link
G M Abca1 ATP-binding cassette, sub-family A (ABC1), member 1 multiple interactions
increases expression
ISO [Sirolimus co-treated with Tacrolimus] results in increased expression of ABCA1 protein
Tacrolimus results in increased expression of ABCA1 mRNA
CTD PMID:17016853 PMID:21865292 NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
JBrowse link
G H ABCA1 ATP binding cassette subfamily A member 1 multiple interactions
increases expression
EXP
ISO
[Sirolimus co-treated with Tacrolimus] results in increased expression of ABCA1 protein
Tacrolimus results in increased expression of ABCA1 mRNA
CTD PMID:17016853 PMID:21865292 NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
JBrowse link
G H ABCB1 ATP binding cassette subfamily B member 1 increases response to substance
decreases activity
affects export
multiple interactions
increases export
affects response to substance
EXP ABCB1 gene SNP results in increased susceptibility to Tacrolimus
Tacrolimus results in decreased activity of ABCB1 protein
ABCB1 protein affects the export of Tacrolimus
[Tacrolimus binds to ABCB1 protein] inhibits the reaction [azidoprazosin binds to ABCB1 protein]; [Tacrolimus results in decreased activity of ABCB1 protein] which results in decreased export of Dexamethasone; Verapamil affects the reaction [ABCB1 protein results in increased export of Tacrolimus]
ABCB1 protein affects the susceptibility to Tacrolimus
CTD PMID:1381629 PMID:11920757 PMID:12352921 PMID:15919446 PMID:15964336 More... NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G R Abcb11 ATP binding cassette subfamily B member 11 decreases activity ISO Tacrolimus results in decreased activity of ABCB11 protein CTD PMID:23956101 NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
JBrowse link
G M Abcb11 ATP-binding cassette, sub-family B (MDR/TAP), member 11 decreases activity ISO Tacrolimus results in decreased activity of ABCB11 protein CTD PMID:23956101 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,960
JBrowse link
G H ABCB11 ATP binding cassette subfamily B member 11 decreases activity EXP Tacrolimus results in decreased activity of ABCB11 protein CTD PMID:23956101 NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
JBrowse link
G R Abcb1a ATP binding cassette subfamily B member 1A affects export
decreases activity
multiple interactions
increases response to substance
increases export
affects response to substance
ISO ABCB1 protein affects the export of Tacrolimus
Tacrolimus results in decreased activity of ABCB1 protein
[Tacrolimus binds to ABCB1 protein] inhibits the reaction [azidoprazosin binds to ABCB1 protein]; [Tacrolimus results in decreased activity of ABCB1 protein] which results in decreased export of Dexamethasone; Verapamil affects the reaction [ABCB1 protein results in increased export of Tacrolimus]
ABCB1 gene SNP results in increased susceptibility to Tacrolimus
ABCB1 protein affects the susceptibility to Tacrolimus
CTD PMID:1381629 PMID:11920757 PMID:12352921 PMID:15919446 PMID:15964336 More... NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
JBrowse link
G M Abcb1a ATP-binding cassette, sub-family B (MDR/TAP), member 1A increases response to substance
decreases activity
affects response to substance
increases export
multiple interactions
affects export
ISO ABCB1 gene SNP results in increased susceptibility to Tacrolimus
Tacrolimus results in decreased activity of ABCB1 protein
ABCB1 protein affects the susceptibility to Tacrolimus
ABCB1 protein results in increased export of Tacrolimus
[Tacrolimus binds to ABCB1 protein] inhibits the reaction [azidoprazosin binds to ABCB1 protein]; [Tacrolimus results in decreased activity of ABCB1 protein] which results in decreased export of Dexamethasone; Verapamil affects the reaction [ABCB1 protein results in increased export of Tacrolimus]
ABCB1 protein affects the export of Tacrolimus
CTD PMID:1381629 PMID:11920757 PMID:12352921 PMID:15919446 PMID:15964336 More... NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G H ACAA1 acetyl-CoA acyltransferase 1 decreases expression ISO Tacrolimus results in decreased expression of ACAA1B mRNA CTD PMID:25270620 NCBI chr 3:38,122,715...38,137,127
Ensembl chr 3:38,103,129...38,137,242
JBrowse link
G R Acaa1b acetyl-Coenzyme A acyltransferase 1B decreases expression ISO Tacrolimus results in decreased expression of ACAA1B mRNA CTD PMID:25270620 NCBI chr 8:118,872,996...118,881,852
Ensembl chr 8:118,872,997...118,881,825
JBrowse link
G M Acaa1b acetyl-Coenzyme A acyltransferase 1B decreases expression EXP Tacrolimus results in decreased expression of ACAA1B mRNA CTD PMID:25270620 NCBI chr 9:118,977,111...118,986,161
Ensembl chr 9:118,977,091...118,986,161
JBrowse link
G R Acadl acyl-CoA dehydrogenase, long chain decreases expression ISO Tacrolimus results in decreased expression of ACADL mRNA CTD PMID:25270620 NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:68,333,980...68,372,220
JBrowse link
G M Acadl acyl-Coenzyme A dehydrogenase, long-chain decreases expression EXP Tacrolimus results in decreased expression of ACADL mRNA CTD PMID:25270620 NCBI chr 1:66,869,998...66,902,468
Ensembl chr 1:66,869,998...66,902,436
JBrowse link
G H ACADL acyl-CoA dehydrogenase long chain decreases expression ISO Tacrolimus results in decreased expression of ACADL mRNA CTD PMID:25270620 NCBI chr 2:210,187,923...210,225,447
Ensembl chr 2:210,187,126...210,225,447
JBrowse link
G R Ace2 angiotensin I converting enzyme 2 decreases expression EXP Tacrolimus results in decreased expression of ACE2 mRNA CTD PMID:21865292 NCBI chr  X:30,293,597...30,340,961
Ensembl chr  X:30,293,589...30,340,977
JBrowse link
G M Ace2 angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 decreases expression ISO Tacrolimus results in decreased expression of ACE2 mRNA CTD PMID:21865292 NCBI chr  X:162,922,338...162,971,414
Ensembl chr  X:162,922,328...162,971,416
JBrowse link
G H ACE2 angiotensin converting enzyme 2 decreases expression ISO Tacrolimus results in decreased expression of ACE2 mRNA CTD PMID:21865292 NCBI chr  X:15,518,197...15,607,211
Ensembl chr  X:15,494,566...15,607,236
JBrowse link
G R Acp5 acid phosphatase 5, tartrate resistant multiple interactions ISO Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:15207740 NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
JBrowse link
G M Acp5 acid phosphatase 5, tartrate resistant multiple interactions EXP Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:15207740 NCBI chr 9:22,038,023...22,047,042
Ensembl chr 9:22,038,023...22,047,007
JBrowse link
G H ACP5 acid phosphatase 5, tartrate resistant multiple interactions ISO Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:15207740 NCBI chr19:11,574,660...11,578,975
Ensembl chr19:11,574,653...11,579,993
JBrowse link
G R Acta2 actin alpha 2, smooth muscle increases expression ISO Tacrolimus results in increased expression of ACTA2 protein CTD PMID:29362864 NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
JBrowse link
G M Acta2 actin alpha 2, smooth muscle, aorta increases expression EXP Tacrolimus results in increased expression of ACTA2 protein CTD PMID:29362864 NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
JBrowse link
G H ACTA2 actin alpha 2, smooth muscle increases expression ISO Tacrolimus results in increased expression of ACTA2 protein CTD PMID:29362864 NCBI chr10:88,935,074...88,991,397
Ensembl chr10:88,935,074...88,991,339
JBrowse link
G R Acvr1b activin A receptor type 1B multiple interactions ISO [Tacrolimus inhibits the reaction [FKBP1A protein binds to ACVR1B protein]] which results in decreased ubiquitination of ACVR1B protein; Tacrolimus inhibits the reaction [FKBP1A protein binds to and results in decreased activity of ACVR1B protein]; Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]] CTD PMID:16720724 NCBI chr 7:132,286,266...132,329,679
Ensembl chr 7:132,286,275...132,329,673
JBrowse link
G M Acvr1b activin A receptor, type 1B multiple interactions ISO [Tacrolimus inhibits the reaction [FKBP1A protein binds to ACVR1B protein]] which results in decreased ubiquitination of ACVR1B protein; Tacrolimus inhibits the reaction [FKBP1A protein binds to and results in decreased activity of ACVR1B protein]; Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]] CTD PMID:16720724 NCBI chr15:101,071,953...101,111,565
Ensembl chr15:101,071,948...101,111,565
JBrowse link
G H ACVR1B activin A receptor type 1B multiple interactions EXP [Tacrolimus inhibits the reaction [FKBP1A protein binds to ACVR1B protein]] which results in decreased ubiquitination of ACVR1B protein; Tacrolimus inhibits the reaction [FKBP1A protein binds to and results in decreased activity of ACVR1B protein]; Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]] CTD PMID:16720724 NCBI chr12:51,951,699...51,997,078
Ensembl chr12:51,951,699...51,997,078
JBrowse link
G R Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression EXP Tacrolimus results in increased expression of ADAMTS1 mRNA CTD PMID:21865292 NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
JBrowse link
G M Adamts1 a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 increases expression ISO Tacrolimus results in increased expression of ADAMTS1 mRNA CTD PMID:21865292 NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
JBrowse link
G H ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif 1 increases expression ISO Tacrolimus results in increased expression of ADAMTS1 mRNA CTD PMID:21865292 NCBI chr21:26,835,755...26,845,409
Ensembl chr21:26,835,755...26,845,409
JBrowse link
G R Adamts2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 increases expression ISO Tacrolimus results in increased expression of ADAMTS2 mRNA CTD PMID:29362864 NCBI chr10:34,920,996...35,126,465
Ensembl chr10:34,921,049...35,123,821
JBrowse link
G M Adamts2 a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 2 increases expression EXP Tacrolimus results in increased expression of ADAMTS2 mRNA CTD PMID:29362864 NCBI chr11:50,492,912...50,698,400
Ensembl chr11:50,492,911...50,698,400
JBrowse link
G H ADAMTS2 ADAM metallopeptidase with thrombospondin type 1 motif 2 increases expression ISO Tacrolimus results in increased expression of ADAMTS2 mRNA CTD PMID:29362864 NCBI chr 5:179,110,853...179,345,461
Ensembl chr 5:179,110,853...179,345,461
JBrowse link
G R Adcy9 adenylate cyclase 9 multiple interactions ISO Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]] CTD PMID:30607468 NCBI chr10:11,138,966...11,262,067
Ensembl chr10:11,139,446...11,262,066
JBrowse link
G M Adcy9 adenylate cyclase 9 multiple interactions ISO Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]] CTD PMID:30607468 NCBI chr16:4,102,750...4,255,094
Ensembl chr16:4,105,393...4,238,362
JBrowse link
G H ADCY9 adenylate cyclase 9 multiple interactions EXP Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]] CTD PMID:30607468 NCBI chr16:3,953,387...4,116,442
Ensembl chr16:3,953,387...4,116,442
JBrowse link
G R Adra1d adrenoceptor alpha 1D increases expression EXP Tacrolimus results in increased expression of ADRA1D mRNA CTD PMID:21865292 NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
JBrowse link
G M Adra1d adrenergic receptor, alpha 1d increases expression ISO Tacrolimus results in increased expression of ADRA1D mRNA CTD PMID:21865292 NCBI chr 2:131,387,277...131,404,417
Ensembl chr 2:131,387,770...131,404,203
JBrowse link
G H ADRA1D adrenoceptor alpha 1D increases expression ISO Tacrolimus results in increased expression of ADRA1D mRNA CTD PMID:21865292 NCBI chr20:4,220,630...4,249,287
Ensembl chr20:4,220,630...4,249,287
JBrowse link
G R Aif1 allograft inflammatory factor 1 increases expression ISO Tacrolimus results in increased expression of AIF1 mRNA CTD PMID:29362864 NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
JBrowse link
G M Aif1 allograft inflammatory factor 1 increases expression EXP Tacrolimus results in increased expression of AIF1 mRNA CTD PMID:29362864 NCBI chr17:35,389,962...35,395,050
Ensembl chr17:35,389,967...35,395,044
JBrowse link
G H AIF1 allograft inflammatory factor 1 increases expression ISO Tacrolimus results in increased expression of AIF1 mRNA CTD PMID:29362864 NCBI chr 6:31,615,234...31,617,015
Ensembl chr 6:31,615,217...31,617,021
JBrowse link
G R Aldh1a1 aldehyde dehydrogenase 1 family, member A1 decreases expression ISO Tacrolimus results in decreased expression of ALDH1A1 mRNA CTD PMID:25270620 NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
JBrowse link
G M Aldh1a1 aldehyde dehydrogenase family 1, subfamily A1 decreases expression EXP Tacrolimus results in decreased expression of ALDH1A1 mRNA CTD PMID:25270620 NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
JBrowse link
G H ALDH1A1 aldehyde dehydrogenase 1 family member A1 decreases expression ISO Tacrolimus results in decreased expression of ALDH1A1 mRNA CTD PMID:25270620 NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
JBrowse link
G M Aldh1a7 aldehyde dehydrogenase family 1, subfamily A7 decreases expression EXP Tacrolimus results in decreased expression of ALDH1A7 mRNA CTD PMID:25270620 NCBI chr19:20,670,317...20,704,920
Ensembl chr19:20,670,317...20,704,926
JBrowse link
G R Aldh2 aldehyde dehydrogenase 2 family member decreases expression ISO Tacrolimus results in decreased expression of ALDH2 mRNA CTD PMID:25270620 NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
JBrowse link
G M Aldh2 aldehyde dehydrogenase 2, mitochondrial decreases expression EXP Tacrolimus results in decreased expression of ALDH2 mRNA CTD PMID:25270620 NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
JBrowse link
G H ALDH2 aldehyde dehydrogenase 2 family member decreases expression ISO Tacrolimus results in decreased expression of ALDH2 mRNA CTD PMID:25270620 NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
JBrowse link
G R Aldh9a1 aldehyde dehydrogenase 9 family, member A1 decreases expression ISO Tacrolimus results in decreased expression of ALDH9A1 mRNA CTD PMID:25270620 NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
JBrowse link
G M Aldh9a1 aldehyde dehydrogenase 9, subfamily A1 decreases expression EXP Tacrolimus results in decreased expression of ALDH9A1 mRNA CTD PMID:25270620 NCBI chr 1:167,177,532...167,196,099
Ensembl chr 1:167,177,560...167,196,101
JBrowse link
G H ALDH9A1 aldehyde dehydrogenase 9 family member A1 decreases expression ISO Tacrolimus results in decreased expression of ALDH9A1 mRNA CTD PMID:25270620 NCBI chr 1:165,662,216...165,698,562
Ensembl chr 1:165,662,216...165,698,562
JBrowse link
G R Alg3 ALG3, alpha-1,3- mannosyltransferase decreases expression ISO Tacrolimus results in decreased expression of ALG3 mRNA CTD PMID:25270620 NCBI chr11:80,300,487...80,306,014
Ensembl chr11:80,300,498...80,307,912
JBrowse link
G M Alg3 asparagine-linked glycosylation 3 (alpha-1,3-mannosyltransferase) decreases expression EXP Tacrolimus results in decreased expression of ALG3 mRNA CTD PMID:25270620 NCBI chr16:20,424,208...20,429,515
Ensembl chr16:20,424,124...20,430,485
JBrowse link
G H ALG3 ALG3 alpha-1,3- mannosyltransferase decreases expression ISO Tacrolimus results in decreased expression of ALG3 mRNA CTD PMID:25270620 NCBI chr 3:184,242,301...184,249,525
Ensembl chr 3:184,242,301...184,249,548
JBrowse link
G R Angptl6 angiopoietin-like 6 increases expression EXP Tacrolimus results in increased expression of ANGPTL6 mRNA CTD PMID:21865292 NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:19,413,619...19,419,925
JBrowse link
G M Angptl6 angiopoietin-like 6 increases expression ISO Tacrolimus results in increased expression of ANGPTL6 mRNA CTD PMID:21865292 NCBI chr 9:20,785,104...20,791,116
Ensembl chr 9:20,785,104...20,791,023
JBrowse link
G H ANGPTL6 angiopoietin like 6 increases expression ISO Tacrolimus results in increased expression of ANGPTL6 mRNA CTD PMID:21865292 NCBI chr19:10,092,338...10,106,190
Ensembl chr19:10,092,338...10,102,678
JBrowse link
G R Ankrd1 ankyrin repeat domain 1 increases expression ISO Tacrolimus results in increased expression of ANKRD1 mRNA CTD PMID:29362864 NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
JBrowse link
G M Ankrd1 ankyrin repeat domain 1 (cardiac muscle) increases expression EXP Tacrolimus results in increased expression of ANKRD1 mRNA CTD PMID:29362864 NCBI chr19:36,089,365...36,097,244
Ensembl chr19:36,089,361...36,097,499
JBrowse link
G H ANKRD1 ankyrin repeat domain 1 increases expression ISO Tacrolimus results in increased expression of ANKRD1 mRNA CTD PMID:29362864 NCBI chr10:90,912,096...90,921,087
Ensembl chr10:90,912,096...90,921,087
JBrowse link
G R Ankrd34a ankyrin repeat domain 34A decreases expression ISO Tacrolimus results in decreased expression of ANKRD34A mRNA CTD PMID:25270620 NCBI chr 2:184,129,830...184,135,075
Ensembl chr 2:184,129,238...184,135,116
JBrowse link
G M Ankrd34a ankyrin repeat domain 34A decreases expression EXP Tacrolimus results in decreased expression of ANKRD34A mRNA CTD PMID:25270620 NCBI chr 3:96,503,244...96,507,442
Ensembl chr 3:96,503,952...96,507,091
JBrowse link
G H ANKRD34A ankyrin repeat domain 34A decreases expression ISO Tacrolimus results in decreased expression of ANKRD34A mRNA CTD PMID:25270620 NCBI chr 1:145,959,441...145,964,575
Ensembl chr 1:145,959,441...145,964,575
JBrowse link
G R Anos1 anosmin 1 increases expression ISO Tacrolimus results in increased expression of WFDC17 mRNA CTD PMID:29362864 NCBI chr10:68,561,954...68,562,801
Ensembl chr10:68,561,954...68,562,801
JBrowse link
G H ANOS1 anosmin 1 increases expression ISO Tacrolimus results in increased expression of WFDC17 mRNA CTD PMID:29362864 NCBI chr  X:8,528,874...8,732,137
Ensembl chr  X:8,528,874...8,732,137
JBrowse link
G R Anpep alanyl aminopeptidase, membrane increases secretion EXP Tacrolimus results in increased secretion of ANPEP protein CTD PMID:7514309 NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
JBrowse link
G M Anpep alanyl (membrane) aminopeptidase increases secretion ISO Tacrolimus results in increased secretion of ANPEP protein CTD PMID:7514309 NCBI chr 7:79,471,551...79,497,958
Ensembl chr 7:79,471,551...79,510,807
JBrowse link
G H ANPEP alanyl aminopeptidase, membrane increases secretion ISO Tacrolimus results in increased secretion of ANPEP protein CTD PMID:7514309 NCBI chr15:89,784,895...89,814,852
Ensembl chr15:89,784,895...89,815,401
JBrowse link
G R Anxa1 annexin A1 increases expression EXP Tacrolimus results in increased expression of ANXA1 CTD PMID:20484890 NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
JBrowse link
G M Anxa1 annexin A1 increases expression ISO Tacrolimus results in increased expression of ANXA1 CTD PMID:20484890 NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
JBrowse link
G H ANXA1 annexin A1 increases expression ISO Tacrolimus results in increased expression of ANXA1 CTD PMID:20484890 NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,393
JBrowse link
G R Aoc1 amine oxidase, copper containing 1 increases expression ISO Tacrolimus results in increased expression of AOC1 mRNA CTD PMID:29362864 NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
JBrowse link
G M Aoc1 amine oxidase, copper-containing 1 increases expression EXP Tacrolimus results in increased expression of AOC1 mRNA CTD PMID:29362864 NCBI chr 6:48,872,189...48,886,122
Ensembl chr 6:48,849,830...48,886,122
JBrowse link
G H AOC1 amine oxidase copper containing 1 increases expression ISO Tacrolimus results in increased expression of AOC1 mRNA CTD PMID:29362864 NCBI chr 7:150,852,120...150,861,504
Ensembl chr 7:150,824,627...150,861,504
JBrowse link
G R Areg amphiregulin increases expression EXP Tacrolimus results in increased expression of AREG mRNA CTD PMID:21865292 NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
JBrowse link
G M Areg amphiregulin increases expression ISO Tacrolimus results in increased expression of AREG mRNA CTD PMID:21865292 NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291
JBrowse link
G H AREG amphiregulin increases expression ISO Tacrolimus results in increased expression of AREG mRNA CTD PMID:21865292 NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005
JBrowse link
G R Arfrp1 ADP-ribosylation factor related protein 1 increases expression ISO Tacrolimus results in increased expression of ARFRP1 mRNA CTD PMID:25270620 NCBI chr 3:168,466,351...168,473,960
Ensembl chr 3:168,466,496...168,473,914
JBrowse link
G M Arfrp1 ADP-ribosylation factor related protein 1 increases expression EXP Tacrolimus results in increased expression of ARFRP1 mRNA CTD PMID:25270620 NCBI chr 2:180,999,483...181,007,197
Ensembl chr 2:180,999,483...181,007,197
JBrowse link
G H ARFRP1 ADP ribosylation factor related protein 1 increases expression ISO Tacrolimus results in increased expression of ARFRP1 mRNA CTD PMID:25270620 NCBI chr20:63,698,647...63,707,976
Ensembl chr20:63,698,642...63,708,025
JBrowse link
G R Arhgap45 Rho GTPase activating protein 45 increases expression ISO Tacrolimus results in increased expression of ARHGAP45 mRNA CTD PMID:21621594 NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:9,674,897...9,690,268
JBrowse link
G M Arhgap45 Rho GTPase activating protein 45 increases expression EXP Tacrolimus results in increased expression of ARHGAP45 mRNA CTD PMID:21621594 NCBI chr10:79,852,505...79,867,305
Ensembl chr10:79,852,487...79,867,306
JBrowse link
G H ARHGAP45 Rho GTPase activating protein 45 increases expression ISO Tacrolimus results in increased expression of ARHGAP45 mRNA CTD PMID:21621594 NCBI chr19:1,065,959...1,086,628
Ensembl chr19:1,065,923...1,086,628
JBrowse link
G R Arhgef11 Rho guanine nucleotide exchange factor 11 increases expression ISO Tacrolimus results in increased expression of ARHGEF11 mRNA CTD PMID:29380240 NCBI chr 2:173,074,383...173,195,962
Ensembl chr 2:173,074,368...173,196,010
JBrowse link
G M Arhgef11 Rho guanine nucleotide exchange factor (GEF) 11 increases expression ISO Tacrolimus results in increased expression of ARHGEF11 mRNA CTD PMID:29380240 NCBI chr 3:87,524,855...87,645,346
Ensembl chr 3:87,524,866...87,645,341
JBrowse link
G H ARHGEF11 Rho guanine nucleotide exchange factor 11 increases expression EXP Tacrolimus results in increased expression of ARHGEF11 mRNA CTD PMID:29380240 NCBI chr 1:156,934,840...157,046,903
Ensembl chr 1:156,934,840...157,045,742
JBrowse link
G R Arpc5 actin related protein 2/3 complex, subunit 5 increases expression ISO Tacrolimus results in increased expression of ARPC5 mRNA CTD PMID:29380240 NCBI chr13:64,904,504...64,913,413
Ensembl chr13:64,887,136...64,913,410
JBrowse link
G M Arpc5 actin related protein 2/3 complex, subunit 5 increases expression ISO Tacrolimus results in increased expression of ARPC5 mRNA CTD PMID:29380240 NCBI chr 1:152,642,293...152,651,331
Ensembl chr 1:152,642,293...152,651,348
JBrowse link
G H ARPC5 actin related protein 2/3 complex subunit 5 increases expression EXP Tacrolimus results in increased expression of ARPC5 mRNA CTD PMID:29380240 NCBI chr 1:183,620,846...183,635,783
Ensembl chr 1:183,620,846...183,635,783
JBrowse link
G R Arv1 ARV1 homolog, fatty acid homeostasis modulator increases expression ISO Tacrolimus results in increased expression of ARV1 mRNA CTD PMID:25270620 NCBI chr19:52,692,337...52,704,156
Ensembl chr19:52,692,337...52,704,156
JBrowse link
G M Arv1 ARV1 homolog, fatty acid homeostasis modulator increases expression EXP Tacrolimus results in increased expression of ARV1 mRNA CTD PMID:25270620 NCBI chr 8:125,448,765...125,469,533
Ensembl chr 8:125,448,878...125,460,862
JBrowse link
G H ARV1 ARV1 homolog, fatty acid homeostasis modulator increases expression ISO Tacrolimus results in increased expression of ARV1 mRNA CTD PMID:25270620 NCBI chr 1:230,979,094...231,000,733
Ensembl chr 1:230,978,981...231,000,733
JBrowse link
G R Asxl3 ASXL transcriptional regulator 3 decreases expression ISO Tacrolimus results in decreased expression of ASXL3 mRNA CTD PMID:29362864 NCBI chr18:13,593,529...13,766,324
Ensembl chr18:13,593,985...13,762,427
JBrowse link
G M Asxl3 ASXL transcriptional regulator 3 decreases expression EXP Tacrolimus results in decreased expression of ASXL3 mRNA CTD PMID:29362864 NCBI chr18:22,477,195...22,663,284
Ensembl chr18:22,477,303...22,663,284
JBrowse link
G H ASXL3 ASXL transcriptional regulator 3 decreases expression ISO Tacrolimus results in decreased expression of ASXL3 mRNA CTD PMID:29362864 NCBI chr18:33,578,219...33,751,195
Ensembl chr18:33,578,219...33,751,195
JBrowse link
G R Atf3 activating transcription factor 3 increases expression ISO Tacrolimus results in increased expression of ATF3 mRNA CTD PMID:23958496 NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
JBrowse link
G M Atf3 activating transcription factor 3 increases expression EXP Tacrolimus results in increased expression of ATF3 mRNA CTD PMID:23958496 NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
JBrowse link
G H ATF3 activating transcription factor 3 increases expression ISO Tacrolimus results in increased expression of ATF3 mRNA CTD PMID:23958496 NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
JBrowse link
G R Atf4 activating transcription factor 4 increases expression ISO Tacrolimus results in increased expression of ATF4 mRNA CTD PMID:23958496 NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
JBrowse link
G M Atf4 activating transcription factor 4 increases expression EXP Tacrolimus results in increased expression of ATF4 mRNA CTD PMID:23958496 NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
JBrowse link
G H ATF4 activating transcription factor 4 increases expression ISO Tacrolimus results in increased expression of ATF4 mRNA CTD PMID:23958496 NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
JBrowse link
G R Atf6 activating transcription factor 6 increases expression ISO Tacrolimus results in increased expression of ATF6 mRNA CTD PMID:23958496 NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
JBrowse link
G M Atf6 activating transcription factor 6 increases expression EXP Tacrolimus results in increased expression of ATF6 mRNA CTD PMID:23958496 NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340
JBrowse link
G H ATF6 activating transcription factor 6 increases expression ISO Tacrolimus results in increased expression of ATF6 mRNA CTD PMID:23958496 NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
JBrowse link
G R Atp1b1 ATPase Na+/K+ transporting subunit beta 1 decreases expression ISO Tacrolimus results in decreased expression of ATP1B1 mRNA CTD PMID:25270620 NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
JBrowse link
G M Atp1b1 ATPase, Na+/K+ transporting, beta 1 polypeptide decreases expression EXP Tacrolimus results in decreased expression of ATP1B1 mRNA CTD PMID:25270620 NCBI chr 1:164,264,668...164,285,924
Ensembl chr 1:164,264,678...164,285,924
JBrowse link
G H ATP1B1 ATPase Na+/K+ transporting subunit beta 1 decreases expression ISO Tacrolimus results in decreased expression of ATP1B1 mRNA CTD PMID:25270620 NCBI chr 1:169,106,690...169,132,719
Ensembl chr 1:169,105,697...169,310,992
JBrowse link
G R Atp1b3 ATPase Na+/K+ transporting subunit beta 3 decreases expression ISO Tacrolimus results in decreased expression of ATP1B3 mRNA CTD PMID:25270620 NCBI chr 8:96,910,265...96,941,592
Ensembl chr 8:96,910,309...96,941,598
JBrowse link
G M Atp1b3 ATPase, Na+/K+ transporting, beta 3 polypeptide decreases expression EXP Tacrolimus results in decreased expression of ATP1B3 mRNA CTD PMID:25270620 NCBI chr 9:96,214,708...96,246,484
Ensembl chr 9:96,214,708...96,246,495
JBrowse link
G H ATP1B3 ATPase Na+/K+ transporting subunit beta 3 decreases expression ISO Tacrolimus results in decreased expression of ATP1B3 mRNA CTD PMID:25270620 NCBI chr 3:141,876,643...141,926,549
Ensembl chr 3:141,876,124...141,926,549
JBrowse link
G R Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 increases expression ISO Tacrolimus results in increased expression of ATP2A2 mRNA CTD PMID:25270620 NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
JBrowse link
G M Atp2a2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 increases expression EXP Tacrolimus results in increased expression of ATP2A2 mRNA CTD PMID:25270620 NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
JBrowse link
G H ATP2A2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 increases expression ISO Tacrolimus results in increased expression of ATP2A2 mRNA CTD PMID:25270620 NCBI chr12:110,281,247...110,351,093
Ensembl chr12:110,280,756...110,351,093
JBrowse link
G R B2m beta-2 microglobulin increases expression ISO Tacrolimus results in increased expression of B2M mRNA CTD PMID:29362864 NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
JBrowse link
G M B2m beta-2 microglobulin increases expression EXP Tacrolimus results in increased expression of B2M mRNA CTD PMID:29362864 NCBI chr 2:121,978,168...121,983,563
Ensembl chr 2:121,978,167...121,983,564
JBrowse link
G H B2M beta-2-microglobulin increases expression ISO Tacrolimus results in increased expression of B2M mRNA CTD PMID:29362864 NCBI chr15:44,711,517...44,718,145
Ensembl chr15:44,711,358...44,718,851
JBrowse link
G R Bad BCL2-associated agonist of cell death multiple interactions EXP
ISO
Tacrolimus inhibits the reaction [Ammonium Chloride results in decreased phosphorylation of BAD protein]
Tacrolimus inhibits the reaction [Rotenone results in decreased phosphorylation of BAD protein]
CTD PMID:15036616 PMID:15280438 NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
JBrowse link
G M Bad BCL2-associated agonist of cell death multiple interactions ISO Tacrolimus inhibits the reaction [Ammonium Chloride results in decreased phosphorylation of BAD protein]
Tacrolimus inhibits the reaction [Rotenone results in decreased phosphorylation of BAD protein]
CTD PMID:15036616 PMID:15280438 NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
JBrowse link
G H BAD BCL2 associated agonist of cell death multiple interactions ISO
EXP
Tacrolimus inhibits the reaction [Ammonium Chloride results in decreased phosphorylation of BAD protein]
Tacrolimus inhibits the reaction [Rotenone results in decreased phosphorylation of BAD protein]
CTD PMID:15036616 PMID:15280438 NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
JBrowse link
G R Batf3 basic leucine zipper ATF-like transcription factor 3 increases expression ISO Tacrolimus results in increased expression of BATF3 mRNA CTD PMID:29362864 NCBI chr13:102,689,657...102,701,241
Ensembl chr13:102,689,657...102,701,139
JBrowse link
G M Batf3 basic leucine zipper transcription factor, ATF-like 3 increases expression EXP Tacrolimus results in increased expression of BATF3 mRNA CTD PMID:29362864 NCBI chr 1:190,830,611...190,841,140
Ensembl chr 1:190,830,044...190,841,142
JBrowse link
G H BATF3 basic leucine zipper ATF-like transcription factor 3 increases expression ISO Tacrolimus results in increased expression of BATF3 mRNA CTD PMID:29362864 NCBI chr 1:212,686,417...212,699,840
Ensembl chr 1:212,686,417...212,699,840
JBrowse link
G R Bax BCL2 associated X, apoptosis regulator multiple interactions
increases expression
ISO
EXP
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein]
Tacrolimus results in increased expression of BAX protein
[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BAX protein
CTD PMID:10205001 PMID:15571979 PMID:27606422 PMID:35033536 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
JBrowse link
G M Bax BCL2-associated X protein multiple interactions
increases expression
EXP
ISO
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein]
Tacrolimus results in increased expression of BAX protein
[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BAX protein
CTD PMID:10205001 PMID:15571979 PMID:27606422 PMID:35033536 NCBI chr 7:45,111,119...45,116,344
Ensembl chr 7:45,111,121...45,116,322
JBrowse link
G H BAX BCL2 associated X, apoptosis regulator multiple interactions
increases expression
ISO
EXP
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein]
Tacrolimus results in increased expression of BAX protein
[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BAX protein
CTD PMID:10205001 PMID:15571979 PMID:27606422 PMID:35033536 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G R Bcl2 BCL2, apoptosis regulator multiple interactions
decreases expression
increases expression
ISO
EXP
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein]
Tacrolimus results in decreased expression of BCL2 protein
[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein
Tacrolimus results in increased expression of BCL2 protein
CTD PMID:10205001 PMID:15571979 PMID:27606422 NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743
JBrowse link
G M Bcl2 B cell leukemia/lymphoma 2 multiple interactions
decreases expression
increases expression
EXP
ISO
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein]
Tacrolimus results in decreased expression of BCL2 protein
[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein
Tacrolimus results in increased expression of BCL2 protein
CTD PMID:10205001 PMID:15571979 PMID:27606422 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G H BCL2 BCL2 apoptosis regulator multiple interactions
decreases expression
increases expression
ISO Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein]
Tacrolimus results in decreased expression of BCL2 protein
[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein
Tacrolimus results in increased expression of BCL2 protein
CTD PMID:10205001 PMID:15571979 PMID:27606422 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G R Bcl2l1 Bcl2-like 1 multiple interactions ISO Tacrolimus inhibits the reaction [Superantigens results in increased expression of BCL2L1 protein] CTD PMID:10532544 NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
JBrowse link
G M Bcl2l1 BCL2-like 1 multiple interactions EXP Tacrolimus inhibits the reaction [Superantigens results in increased expression of BCL2L1 protein] CTD PMID:10532544 NCBI chr 2:152,600,652...152,675,723
Ensembl chr 2:152,622,588...152,673,648
JBrowse link
G H BCL2L1 BCL2 like 1 multiple interactions ISO Tacrolimus inhibits the reaction [Superantigens results in increased expression of BCL2L1 protein] CTD PMID:10532544 NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
JBrowse link
G R Bcl3 BCL3, transcription coactivator increases expression ISO Tacrolimus results in increased expression of BCL3 mRNA CTD PMID:23958496 NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
JBrowse link
G M Bcl3 B cell leukemia/lymphoma 3 increases expression EXP Tacrolimus results in increased expression of BCL3 mRNA CTD PMID:23958496 NCBI chr 7:19,542,387...19,556,691
Ensembl chr 7:19,542,387...19,556,695
JBrowse link
G H BCL3 BCL3 transcription coactivator increases expression ISO Tacrolimus results in increased expression of BCL3 mRNA CTD PMID:23958496 NCBI chr19:44,747,705...44,760,044
Ensembl chr19:44,747,705...44,760,044
JBrowse link
G R Bdnf brain-derived neurotrophic factor multiple interactions EXP Tacrolimus inhibits the reaction [decamethrin results in increased expression of BDNF exon]; Tacrolimus promotes the reaction [U 0126 inhibits the reaction [decamethrin results in increased expression of BDNF exon]]; U 0126 promotes the reaction [Tacrolimus inhibits the reaction [decamethrin results in increased expression of BDNF exon]] CTD PMID:22079160 NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
JBrowse link
G M Bdnf brain derived neurotrophic factor multiple interactions ISO Tacrolimus inhibits the reaction [decamethrin results in increased expression of BDNF exon]; Tacrolimus promotes the reaction [U 0126 inhibits the reaction [decamethrin results in increased expression of BDNF exon]]; U 0126 promotes the reaction [Tacrolimus inhibits the reaction [decamethrin results in increased expression of BDNF exon]] CTD PMID:22079160 NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
JBrowse link
G H BDNF brain derived neurotrophic factor multiple interactions ISO Tacrolimus inhibits the reaction [decamethrin results in increased expression of BDNF exon]; Tacrolimus promotes the reaction [U 0126 inhibits the reaction [decamethrin results in increased expression of BDNF exon]]; U 0126 promotes the reaction [Tacrolimus inhibits the reaction [decamethrin results in increased expression of BDNF exon]] CTD PMID:22079160 NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
JBrowse link
G R Birc3 baculoviral IAP repeat-containing 3 increases expression EXP Tacrolimus results in increased expression of BIRC3 mRNA CTD PMID:21865292 NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
JBrowse link
G M Birc3 baculoviral IAP repeat-containing 3 increases expression ISO Tacrolimus results in increased expression of BIRC3 mRNA CTD PMID:21865292 NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
JBrowse link
G H BIRC3 baculoviral IAP repeat containing 3 increases expression ISO Tacrolimus results in increased expression of BIRC3 mRNA CTD PMID:21865292 NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,450...102,339,403
JBrowse link
G R Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO Tacrolimus results in decreased expression of BIRC5 mRNA CTD PMID:16574167 NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
JBrowse link
G M Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO Tacrolimus results in decreased expression of BIRC5 mRNA CTD PMID:16574167 NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
JBrowse link
G H BIRC5 baculoviral IAP repeat containing 5 decreases expression EXP Tacrolimus results in decreased expression of BIRC5 mRNA CTD PMID:16574167 NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
JBrowse link
G R Bmp7 bone morphogenetic protein 7 multiple interactions
decreases expression
EXP Ramipril inhibits the reaction [Tacrolimus results in decreased expression of BMP7 protein]; valsartan inhibits the reaction [Tacrolimus results in decreased expression of BMP7 protein] CTD PMID:17703430 NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
JBrowse link
G M Bmp7 bone morphogenetic protein 7 multiple interactions
decreases expression
ISO Ramipril inhibits the reaction [Tacrolimus results in decreased expression of BMP7 protein]; valsartan inhibits the reaction [Tacrolimus results in decreased expression of BMP7 protein] CTD PMID:17703430 NCBI chr 2:172,709,805...172,782,114
Ensembl chr 2:172,709,805...172,782,114
JBrowse link
G H BMP7 bone morphogenetic protein 7 multiple interactions
decreases expression
ISO Ramipril inhibits the reaction [Tacrolimus results in decreased expression of BMP7 protein]; valsartan inhibits the reaction [Tacrolimus results in decreased expression of BMP7 protein] CTD PMID:17703430 NCBI chr20:57,168,753...57,266,641
Ensembl chr20:57,168,753...57,266,641
JBrowse link
G R Btg2 BTG anti-proliferation factor 2 increases expression EXP Tacrolimus results in increased expression of BTG2 mRNA CTD PMID:21865292 NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
JBrowse link
G M Btg2 BTG anti-proliferation factor 2 increases expression ISO Tacrolimus results in increased expression of BTG2 mRNA CTD PMID:21865292 NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
JBrowse link
G H BTG2 BTG anti-proliferation factor 2 increases expression ISO Tacrolimus results in increased expression of BTG2 mRNA CTD PMID:21865292 NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
JBrowse link
G R Btnl9 butyrophilin-like 9 decreases expression ISO Tacrolimus results in decreased expression of BTNL9 mRNA CTD PMID:29362864 NCBI chr10:33,466,059...33,489,229
Ensembl chr10:33,470,536...33,489,025
JBrowse link
G M Btnl9 butyrophilin-like 9 decreases expression EXP Tacrolimus results in decreased expression of BTNL9 mRNA CTD PMID:29362864 NCBI chr11:49,059,152...49,077,916
Ensembl chr11:49,056,412...49,077,986
JBrowse link
G H BTNL9 butyrophilin like 9 decreases expression ISO Tacrolimus results in decreased expression of BTNL9 mRNA CTD PMID:29362864 NCBI chr 5:181,040,266...181,061,521
Ensembl chr 5:181,040,225...181,061,521
JBrowse link
G R C1qa complement C1q A chain increases expression ISO Tacrolimus results in increased expression of C1QA mRNA CTD PMID:29362864 NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
JBrowse link
G M C1qa complement component 1, q subcomponent, alpha polypeptide increases expression EXP Tacrolimus results in increased expression of C1QA mRNA CTD PMID:29362864 NCBI chr 4:136,623,227...136,626,155
Ensembl chr 4:136,623,228...136,626,114
JBrowse link
G H C1QA complement C1q A chain increases expression ISO Tacrolimus results in increased expression of C1QA mRNA CTD PMID:29362864 NCBI chr 1:22,636,463...22,639,678
Ensembl chr 1:22,635,077...22,639,678
JBrowse link
G R C1qb complement C1q B chain increases expression ISO Tacrolimus results in increased expression of C1QB mRNA CTD PMID:29362864 NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
JBrowse link
G M C1qb complement component 1, q subcomponent, beta polypeptide increases expression EXP Tacrolimus results in increased expression of C1QB mRNA CTD PMID:29362864 NCBI chr 4:136,607,437...136,613,511
Ensembl chr 4:136,607,440...136,613,498
JBrowse link
G H C1QB complement C1q B chain increases expression ISO Tacrolimus results in increased expression of C1QB mRNA CTD PMID:29362864 NCBI chr 1:22,653,236...22,661,637
Ensembl chr 1:22,652,762...22,661,637
JBrowse link
G R C1qc complement C1q C chain increases expression ISO Tacrolimus results in increased expression of C1QC mRNA CTD PMID:29362864 NCBI chr 5:149,127,424...149,130,732
Ensembl chr 5:149,127,415...149,131,017
JBrowse link
G M C1qc complement component 1, q subcomponent, C chain increases expression EXP Tacrolimus results in increased expression of C1QC mRNA CTD PMID:29362864 NCBI chr 4:136,617,112...136,620,242
Ensembl chr 4:136,617,115...136,620,376
JBrowse link
G H C1QC complement C1q C chain increases expression ISO Tacrolimus results in increased expression of C1QC mRNA CTD PMID:29362864 NCBI chr 1:22,643,633...22,648,108
Ensembl chr 1:22,643,014...22,648,110
JBrowse link
G M C1ra complement component 1, r subcomponent A increases expression EXP Tacrolimus results in increased expression of C1RA mRNA CTD PMID:29362864 NCBI chr 6:124,489,580...124,500,399
Ensembl chr 6:124,489,364...124,500,402
JBrowse link
G R C2 complement C2 increases expression EXP Tacrolimus results in increased expression of C2 mRNA CTD PMID:21865292 NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
JBrowse link
G M C2 complement component 2 (within H-2S) increases expression ISO Tacrolimus results in increased expression of C2 mRNA CTD PMID:21865292 NCBI chr17:35,081,578...35,101,076
Ensembl chr17:35,081,580...35,117,241
JBrowse link
G H C2 complement C2 increases expression ISO Tacrolimus results in increased expression of C2 mRNA CTD PMID:21865292 NCBI chr 6:31,897,783...31,945,672
Ensembl chr 6:31,897,785...31,945,673
JBrowse link
G R C3 complement C3 increases expression EXP
ISO
Tacrolimus results in increased expression of C3 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
JBrowse link
G M C3 complement component 3 increases expression ISO
EXP
Tacrolimus results in increased expression of C3 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
JBrowse link
G H C3 complement C3 increases expression ISO Tacrolimus results in increased expression of C3 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
JBrowse link
G R C4b complement C4B (Chido blood group) increases expression EXP Tacrolimus results in increased expression of C4B mRNA CTD PMID:21865292 NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
JBrowse link
G M C4b complement component 4B (Chido blood group) increases expression ISO Tacrolimus results in increased expression of C4B mRNA CTD PMID:21865292 NCBI chr17:34,947,249...34,962,876
Ensembl chr17:34,947,354...34,962,856
JBrowse link
G H C4B complement C4B (Chido blood group) increases expression ISO Tacrolimus results in increased expression of C4B mRNA CTD PMID:21865292 NCBI chr 6:32,014,795...32,035,418
Ensembl chr 6:32,014,795...32,035,418
JBrowse link
G R Calb1 calbindin 1 decreases expression EXP Tacrolimus results in decreased expression of CALB1 mRNA; Tacrolimus results in decreased expression of CALB1 protein CTD PMID:14978156 PMID:21865292 NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
JBrowse link
G M Calb1 calbindin 1 decreases expression ISO Tacrolimus results in decreased expression of CALB1 mRNA; Tacrolimus results in decreased expression of CALB1 protein CTD PMID:14978156 PMID:21865292 NCBI chr 4:15,881,264...15,906,709
Ensembl chr 4:15,881,264...15,908,064
JBrowse link
G H CALB1 calbindin 1 decreases expression ISO Tacrolimus results in decreased expression of CALB1 mRNA; Tacrolimus results in decreased expression of CALB1 protein CTD PMID:14978156 PMID:21865292 NCBI chr 8:90,058,608...90,082,879
Ensembl chr 8:90,058,608...90,095,475
JBrowse link
G R Calcr calcitonin receptor multiple interactions ISO Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA] CTD PMID:21869564 NCBI chr 4:31,661,270...31,736,392
Ensembl chr 4:31,661,273...31,736,392
JBrowse link
G M Calcr calcitonin receptor multiple interactions EXP Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA] CTD PMID:21869564 NCBI chr 6:3,685,678...3,764,713
Ensembl chr 6:3,685,680...3,764,714
JBrowse link
G H CALCR calcitonin receptor multiple interactions ISO Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA] CTD PMID:21869564 NCBI chr 7:93,424,486...93,574,724
Ensembl chr 7:93,424,486...93,574,730
JBrowse link
G R Calr calreticulin increases expression ISO Tacrolimus results in increased expression of CALR mRNA CTD PMID:25270620 NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
JBrowse link
G M Calr calreticulin increases expression EXP Tacrolimus results in increased expression of CALR mRNA CTD PMID:25270620 NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
JBrowse link
G H CALR calreticulin increases expression ISO Tacrolimus results in increased expression of CALR mRNA CTD PMID:25270620 NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
JBrowse link
G R Camk1d calcium/calmodulin-dependent protein kinase ID increases expression ISO Tacrolimus results in increased expression of CAMK1D mRNA CTD PMID:23958496 NCBI chr17:72,581,899...72,982,704
Ensembl chr17:72,581,979...72,980,556
JBrowse link
G M Camk1d calcium/calmodulin-dependent protein kinase ID increases expression EXP Tacrolimus results in increased expression of CAMK1D mRNA CTD PMID:23958496 NCBI chr 2:5,298,268...5,719,665
Ensembl chr 2:5,298,268...5,719,326
JBrowse link
G H CAMK1D calcium/calmodulin dependent protein kinase ID increases expression ISO Tacrolimus results in increased expression of CAMK1D mRNA CTD PMID:23958496 NCBI chr10:12,349,547...12,835,545
Ensembl chr10:12,349,547...12,835,545
JBrowse link
G R Capg capping actin protein, gelsolin like increases expression EXP Tacrolimus results in increased expression of CAPG mRNA CTD PMID:21865292 NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
JBrowse link
G M Capg capping protein (actin filament), gelsolin-like increases expression ISO Tacrolimus results in increased expression of CAPG mRNA CTD PMID:21865292 NCBI chr 6:72,515,265...72,539,966
Ensembl chr 6:72,521,374...72,539,966
JBrowse link
G H CAPG capping actin protein, gelsolin like increases expression ISO Tacrolimus results in increased expression of CAPG mRNA CTD PMID:21865292 NCBI chr 2:85,391,602...85,419,540
Ensembl chr 2:85,394,753...85,418,432
JBrowse link
G P CASP3 caspase 3 increases activity EXP Tacrolimus results in increased activity of CASP3 protein CTD PMID:14675044 NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
JBrowse link
G R Casp3 caspase 3 multiple interactions
increases cleavage
increases activity
ISO
EXP
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Thapsigargin results in increased activity of CASP3 protein]
Tacrolimus results in increased cleavage of CASP3 protein
Tacrolimus results in increased activity of CASP3 protein
MK0626 inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; NGF protein inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [3-nitropropionic acid results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [S-Nitrosoglutathione results in increased activity of CASP3 protein]
CTD PMID:10205001 PMID:12642403 PMID:12871656 PMID:12892836 PMID:15207740 More... NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G M Casp3 caspase 3 multiple interactions
increases cleavage
increases activity
ISO
EXP
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Thapsigargin results in increased activity of CASP3 protein]
Tacrolimus results in increased cleavage of CASP3 protein
Tacrolimus results in increased activity of CASP3 protein
MK0626 inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; NGF protein inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [3-nitropropionic acid results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [S-Nitrosoglutathione results in increased activity of CASP3 protein]
CTD PMID:10205001 PMID:12642403 PMID:12871656 PMID:12892836 PMID:15207740 More... NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G H CASP3 caspase 3 multiple interactions
increases cleavage
increases activity
EXP
ISO
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Thapsigargin results in increased activity of CASP3 protein]
Tacrolimus results in increased cleavage of CASP3 protein
Tacrolimus results in increased activity of CASP3 protein
MK0626 inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; NGF protein inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [3-nitropropionic acid results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [S-Nitrosoglutathione results in increased activity of CASP3 protein]
CTD PMID:10205001 PMID:12642403 PMID:12871656 PMID:12892836 PMID:15207740 More... NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G R Casp8 caspase 8 multiple interactions
increases expression
ISO Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP8 protein]
Tacrolimus results in increased expression of CASP8 protein
CTD PMID:15548389 PMID:27606422 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
JBrowse link
G M Casp8 caspase 8 multiple interactions
increases expression
ISO
EXP
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP8 protein]
Tacrolimus results in increased expression of CASP8 protein
CTD PMID:15548389 PMID:27606422 NCBI chr 1:58,834,398...58,886,662
Ensembl chr 1:58,834,533...58,886,662
JBrowse link
G H CASP8 caspase 8 multiple interactions
increases expression
EXP
ISO
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP8 protein]
Tacrolimus results in increased expression of CASP8 protein
CTD PMID:15548389 PMID:27606422 NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,361,836
JBrowse link
G R Casp9 caspase 9 multiple interactions
increases expression
ISO Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein]
Tacrolimus results in increased expression of CASP9 protein
CTD PMID:15548389 PMID:27606422 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
JBrowse link
G M Casp9 caspase 9 multiple interactions
increases expression
ISO
EXP
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein]
Tacrolimus results in increased expression of CASP9 protein
CTD PMID:15548389 PMID:27606422 NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
JBrowse link
G H CASP9 caspase 9 multiple interactions
increases expression
EXP
ISO
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein]
Tacrolimus results in increased expression of CASP9 protein
CTD PMID:15548389 PMID:27606422 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G R Cat catalase increases expression
decreases response to substance
EXP
ISO
Tacrolimus results in increased expression of CAT protein
CAT protein results in decreased susceptibility to Tacrolimus
CTD PMID:14675044 PMID:18766458 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
JBrowse link
G M Cat catalase increases expression
decreases response to substance
ISO Tacrolimus results in increased expression of CAT protein
CAT protein results in decreased susceptibility to Tacrolimus
CTD PMID:14675044 PMID:18766458 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G H CAT catalase increases expression
decreases response to substance
ISO
EXP
Tacrolimus results in increased expression of CAT protein
CAT protein results in decreased susceptibility to Tacrolimus
CTD PMID:14675044 PMID:18766458 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G R Cbll1 Cbl proto-oncogene like 1 increases expression ISO Tacrolimus results in increased expression of CBLL1 mRNA CTD PMID:21621594 NCBI chr 6:48,071,190...48,086,174
Ensembl chr 6:48,071,190...48,086,444
JBrowse link
G M Cbll1 Casitas B-lineage lymphoma-like 1 increases expression EXP Tacrolimus results in increased expression of CBLL1 mRNA CTD PMID:21621594 NCBI chr12:31,534,828...31,550,675
Ensembl chr12:31,534,828...31,549,615
JBrowse link
G H CBLL1 Cbl proto-oncogene like 1 increases expression ISO Tacrolimus results in increased expression of CBLL1 mRNA CTD PMID:21621594 NCBI chr 7:107,744,142...107,761,667
Ensembl chr 7:107,743,073...107,761,667
JBrowse link
G R Ccdc88b coiled-coil domain containing 88B increases expression ISO Tacrolimus results in increased expression of CCDC88B mRNA CTD PMID:29362864 NCBI chr 1:204,036,913...204,052,878
Ensembl chr 1:204,036,918...204,052,970
JBrowse link
G M Ccdc88b coiled-coil domain containing 88B increases expression EXP Tacrolimus results in increased expression of CCDC88B mRNA CTD PMID:29362864 NCBI chr19:6,821,991...6,835,586
Ensembl chr19:6,821,991...6,835,579
JBrowse link
G H CCDC88B coiled-coil domain containing 88B increases expression ISO Tacrolimus results in increased expression of CCDC88B mRNA CTD PMID:29362864 NCBI chr11:64,340,204...64,357,534
Ensembl chr11:64,340,204...64,357,534
JBrowse link
G R Ccl11 C-C motif chemokine ligand 11 decreases expression ISO Tacrolimus results in decreased expression of CCL11 mRNA CTD PMID:15948978 NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
JBrowse link
G M Ccl11 chemokine (C-C motif) ligand 11 decreases expression ISO Tacrolimus results in decreased expression of CCL11 mRNA CTD PMID:15948978 NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
JBrowse link
G H CCL11 C-C motif chemokine ligand 11 decreases expression EXP Tacrolimus results in decreased expression of CCL11 mRNA CTD PMID:15948978 NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
JBrowse link
G H CCL15 C-C motif chemokine ligand 15 increases expression ISO Tacrolimus results in increased expression of CCL6 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr17:35,997,582...36,001,553
Ensembl chr17:35,996,440...36,001,553
JBrowse link
G R Ccl17 C-C motif chemokine ligand 17 increases expression ISO Tacrolimus results in increased expression of CCL17 mRNA CTD PMID:29362864 NCBI chr19:10,202,317...10,203,768
Ensembl chr19:10,202,128...10,203,819
JBrowse link
G M Ccl17 chemokine (C-C motif) ligand 17 increases expression EXP Tacrolimus results in increased expression of CCL17 mRNA CTD PMID:29362864 NCBI chr 8:95,535,996...95,538,666
Ensembl chr 8:95,537,081...95,538,664
JBrowse link
G H CCL17 C-C motif chemokine ligand 17 increases expression ISO Tacrolimus results in increased expression of CCL17 mRNA CTD PMID:29362864 NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
JBrowse link
G R Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression
EXP
ISO
pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]
7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]
CTD PMID:12472797 PMID:23958496 PMID:29362864 NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
JBrowse link
G M Ccl2 chemokine (C-C motif) ligand 2 multiple interactions
increases expression
EXP
ISO
7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]
pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]
CTD PMID:12472797 PMID:23958496 PMID:29362864 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G H CCL2 C-C motif chemokine ligand 2 multiple interactions
increases expression
ISO 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]
pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]
CTD PMID:12472797 PMID:23958496 PMID:29362864 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
JBrowse link
G R Ccl20 C-C motif chemokine ligand 20 increases expression ISO Tacrolimus results in increased expression of CCL20 mRNA CTD PMID:23958496 NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
JBrowse link
G M Ccl20 chemokine (C-C motif) ligand 20 increases expression EXP Tacrolimus results in increased expression of CCL20 mRNA CTD PMID:23958496 NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
JBrowse link
G H CCL20 C-C motif chemokine ligand 20 increases expression ISO Tacrolimus results in increased expression of CCL20 mRNA CTD PMID:23958496 NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
JBrowse link
G R Ccl5 C-C motif chemokine ligand 5 decreases expression
increases expression
multiple interactions
ISO Tacrolimus results in decreased expression of CCL5 mRNA
Tacrolimus results in increased expression of CCL5 mRNA
7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]
CTD PMID:15948978 PMID:23958496 PMID:25270620 NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
JBrowse link
G M Ccl5 chemokine (C-C motif) ligand 5 decreases expression
increases expression
multiple interactions
ISO
EXP
Tacrolimus results in decreased expression of CCL5 mRNA
Tacrolimus results in increased expression of CCL5 mRNA
7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]
CTD PMID:15948978 PMID:23958496 PMID:25270620 NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
JBrowse link
G H CCL5 C-C motif chemokine ligand 5 decreases expression
increases expression
multiple interactions
EXP
ISO
Tacrolimus results in decreased expression of CCL5 mRNA
Tacrolimus results in increased expression of CCL5 mRNA
7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]
CTD PMID:15948978 PMID:23958496 PMID:25270620 NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
JBrowse link
G M Ccl6 chemokine (C-C motif) ligand 6 increases expression EXP
ISO
Tacrolimus results in increased expression of CCL6 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr11:83,478,712...83,483,913
Ensembl chr11:83,478,708...83,483,913
JBrowse link
G R Ccl7 C-C motif chemokine ligand 7 increases expression ISO Tacrolimus results in increased expression of CCL7 mRNA CTD PMID:23958496 PMID:29362864 NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
JBrowse link
G M Ccl7 chemokine (C-C motif) ligand 7 increases expression EXP Tacrolimus results in increased expression of CCL7 mRNA CTD PMID:23958496 PMID:29362864 NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
JBrowse link
G H CCL7 C-C motif chemokine ligand 7 increases expression ISO Tacrolimus results in increased expression of CCL7 mRNA CTD PMID:23958496 PMID:29362864 NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
JBrowse link
G M Ccl8 chemokine (C-C motif) ligand 8 increases expression EXP Tacrolimus results in increased expression of CCL8 mRNA CTD PMID:29362864 NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
JBrowse link
G R Ccl9 C-C motif chemokine ligand 9 increases expression EXP
ISO
Tacrolimus results in increased expression of CCL6 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
JBrowse link
G R Ccn2 cellular communication network factor 2 multiple interactions EXP Tacrolimus inhibits the reaction [Paraquat results in increased expression of CCN2 mRNA]; Tacrolimus inhibits the reaction [Paraquat results in increased secretion of CCN2 protein] CTD PMID:33000210 NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
JBrowse link
G M Ccn2 cellular communication network factor 2 multiple interactions ISO Tacrolimus inhibits the reaction [Paraquat results in increased expression of CCN2 mRNA]; Tacrolimus inhibits the reaction [Paraquat results in increased secretion of CCN2 protein] CTD PMID:33000210 NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
JBrowse link
G H CCN2 cellular communication network factor 2 multiple interactions ISO Tacrolimus inhibits the reaction [Paraquat results in increased expression of CCN2 mRNA]; Tacrolimus inhibits the reaction [Paraquat results in increased secretion of CCN2 protein] CTD PMID:33000210 NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
JBrowse link
G R Ccna2 cyclin A2 increases expression ISO Tacrolimus results in increased expression of CCNA2 mRNA CTD PMID:29362864 NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
JBrowse link
G M Ccna2 cyclin A2 increases expression EXP Tacrolimus results in increased expression of CCNA2 mRNA CTD PMID:29362864 NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
JBrowse link
G H CCNA2 cyclin A2 increases expression ISO Tacrolimus results in increased expression of CCNA2 mRNA CTD PMID:29362864 NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
JBrowse link
G R Ccnb2 cyclin B2 decreases expression
increases expression
ISO Tacrolimus results in decreased expression of CCNB2 mRNA
Tacrolimus results in increased expression of CCNB2 mRNA
CTD PMID:16574167 PMID:29362864 NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
JBrowse link
G M Ccnb2 cyclin B2 decreases expression
increases expression
ISO
EXP
Tacrolimus results in decreased expression of CCNB2 mRNA
Tacrolimus results in increased expression of CCNB2 mRNA
CTD PMID:16574167 PMID:29362864 NCBI chr 9:70,314,971...70,328,836
Ensembl chr 9:70,314,974...70,328,829
JBrowse link
G H CCNB2 cyclin B2 decreases expression
increases expression
EXP
ISO
Tacrolimus results in decreased expression of CCNB2 mRNA
Tacrolimus results in increased expression of CCNB2 mRNA
CTD PMID:16574167 PMID:29362864 NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
JBrowse link
G R Ccr2 C-C motif chemokine receptor 2 increases expression ISO Tacrolimus results in increased expression of CCR2 mRNA CTD PMID:29362864 NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
JBrowse link
G M Ccr2 chemokine (C-C motif) receptor 2 increases expression EXP Tacrolimus results in increased expression of CCR2 mRNA CTD PMID:29362864 NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
JBrowse link
G H CCR2 C-C motif chemokine receptor 2 increases expression ISO Tacrolimus results in increased expression of CCR2 mRNA CTD PMID:29362864 NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
JBrowse link
G R Ccr3 C-C motif chemokine receptor 3 decreases expression ISO Tacrolimus results in decreased expression of CCR3 mRNA CTD PMID:15948978 NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
JBrowse link
G M Ccr3 chemokine (C-C motif) receptor 3 decreases expression ISO Tacrolimus results in decreased expression of CCR3 mRNA CTD PMID:15948978 NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
JBrowse link
G H CCR3 C-C motif chemokine receptor 3 decreases expression EXP Tacrolimus results in decreased expression of CCR3 mRNA CTD PMID:15948978 NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
JBrowse link
G R Ccrl2 C-C motif chemokine receptor like 2 increases expression ISO Tacrolimus results in increased expression of CCRL2 mRNA CTD PMID:23958496 NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
JBrowse link
G M Ccrl2 chemokine (C-C motif) receptor-like 2 increases expression EXP Tacrolimus results in increased expression of CCRL2 mRNA CTD PMID:23958496 NCBI chr 9:110,883,902...110,886,586
Ensembl chr 9:110,883,554...110,886,587
JBrowse link
G H CCRL2 C-C motif chemokine receptor like 2 increases expression ISO Tacrolimus results in increased expression of CCRL2 mRNA CTD PMID:23958496 NCBI chr 3:46,407,259...46,409,523
Ensembl chr 3:46,407,166...46,412,997
JBrowse link
G R Cd2 Cd2 molecule multiple interactions ISO Tacrolimus inhibits the reaction [CD2 protein results in increased expression of IL2 protein] CTD PMID:1705513 NCBI chr 2:188,710,895...188,724,044
Ensembl chr 2:188,710,900...188,724,026
JBrowse link
G M Cd2 CD2 antigen multiple interactions ISO Tacrolimus inhibits the reaction [CD2 protein results in increased expression of IL2 protein] CTD PMID:1705513 NCBI chr 3:101,183,224...101,195,255
Ensembl chr 3:101,183,215...101,195,255
JBrowse link
G H CD2 CD2 molecule multiple interactions EXP Tacrolimus inhibits the reaction [CD2 protein results in increased expression of IL2 protein] CTD PMID:1705513 NCBI chr 1:116,754,430...116,769,229
Ensembl chr 1:116,754,430...116,769,229
JBrowse link
G R Cd44 CD44 molecule (Indian blood group) increases expression EXP Tacrolimus results in increased expression of CD44 mRNA CTD PMID:21865292 NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
JBrowse link
G M Cd44 CD44 antigen increases expression ISO Tacrolimus results in increased expression of CD44 mRNA CTD PMID:21865292 NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
JBrowse link
G H CD44 CD44 molecule (Indian blood group) increases expression ISO Tacrolimus results in increased expression of CD44 mRNA CTD PMID:21865292 NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
JBrowse link
G R Cd68 Cd68 molecule increases expression EXP Tacrolimus results in increased expression of CD68 mRNA CTD PMID:21865292 NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
JBrowse link
G M Cd68 CD68 antigen increases expression ISO Tacrolimus results in increased expression of CD68 mRNA CTD PMID:21865292 NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979
JBrowse link
G H CD68 CD68 molecule increases expression ISO Tacrolimus results in increased expression of CD68 mRNA CTD PMID:21865292 NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111
JBrowse link
G R Cd74 CD74 molecule increases expression ISO Tacrolimus results in increased expression of CD74 mRNA CTD PMID:23958496 NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
JBrowse link
G M Cd74 CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) increases expression EXP Tacrolimus results in increased expression of CD74 mRNA CTD PMID:23958496 NCBI chr18:60,936,921...60,945,724
Ensembl chr18:60,936,920...60,945,724
JBrowse link
G H CD74 CD74 molecule increases expression ISO Tacrolimus results in increased expression of CD74 mRNA CTD PMID:23958496 NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969
JBrowse link
G R Cd80 Cd80 molecule decreases expression ISO Tacrolimus results in decreased expression of CD80 protein CTD PMID:15241357 NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
JBrowse link
G M Cd80 CD80 antigen decreases expression ISO Tacrolimus results in decreased expression of CD80 protein CTD PMID:15241357 NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697
JBrowse link
G H CD80 CD80 molecule decreases expression EXP Tacrolimus results in decreased expression of CD80 protein CTD PMID:15241357 NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
JBrowse link
G R Cd83 CD83 molecule increases expression ISO Tacrolimus results in increased expression of CD83 mRNA CTD PMID:29362864 NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
JBrowse link
G M Cd83 CD83 antigen increases expression EXP Tacrolimus results in increased expression of CD83 mRNA CTD PMID:29362864 NCBI chr13:43,938,588...43,956,609
Ensembl chr13:43,938,251...43,956,608
JBrowse link
G H CD83 CD83 molecule increases expression ISO Tacrolimus results in increased expression of CD83 mRNA CTD PMID:29362864 NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,136,918
JBrowse link
G R Cd86 CD86 molecule decreases expression ISO Tacrolimus results in decreased expression of CD86 protein CTD PMID:15241357 NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
JBrowse link
G M Cd86 CD86 antigen decreases expression ISO Tacrolimus results in decreased expression of CD86 protein CTD PMID:15241357 NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
JBrowse link
G H CD86 CD86 molecule decreases expression EXP Tacrolimus results in decreased expression of CD86 protein CTD PMID:15241357 NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
JBrowse link
G R Cdca3 cell division cycle associated 3 increases expression ISO Tacrolimus results in increased expression of CDCA3 mRNA CTD PMID:29362864 NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
JBrowse link
G M Cdca3 cell division cycle associated 3 increases expression EXP Tacrolimus results in increased expression of CDCA3 mRNA CTD PMID:29362864 NCBI chr 6:124,806,533...124,810,664
Ensembl chr 6:124,806,510...124,810,664
JBrowse link
G H CDCA3 cell division cycle associated 3 increases expression ISO Tacrolimus results in increased expression of CDCA3 mRNA CTD PMID:29362864 NCBI chr12:6,844,798...6,851,286
Ensembl chr12:6,844,793...6,851,292
JBrowse link
G R Cdca5 cell division cycle associated 5 increases expression ISO Tacrolimus results in increased expression of CDCA5 mRNA CTD PMID:29362864 NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
JBrowse link
G M Cdca5 cell division cycle associated 5 increases expression EXP Tacrolimus results in increased expression of CDCA5 mRNA CTD PMID:29362864 NCBI chr19:6,135,127...6,141,803
Ensembl chr19:6,135,013...6,141,807
JBrowse link
G H CDCA5 cell division cycle associated 5 increases expression ISO Tacrolimus results in increased expression of CDCA5 mRNA CTD PMID:29362864 NCBI chr11:65,061,093...65,084,040
Ensembl chr11:65,066,300...65,084,164
JBrowse link
G R Cdca8 cell division cycle associated 8 increases expression ISO Tacrolimus results in increased expression of CDCA8 mRNA CTD PMID:29362864 NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
JBrowse link
G M Cdca8 cell division cycle associated 8 increases expression EXP Tacrolimus results in increased expression of CDCA8 mRNA CTD PMID:29362864 NCBI chr 4:124,812,258...124,830,710
Ensembl chr 4:124,812,258...124,833,104
JBrowse link
G H CDCA8 cell division cycle associated 8 increases expression ISO Tacrolimus results in increased expression of CDCA8 mRNA CTD PMID:29362864 NCBI chr 1:37,692,516...37,709,719
Ensembl chr 1:37,692,481...37,709,719
JBrowse link
G R Cdh1 cadherin 1 decreases expression ISO Tacrolimus results in decreased expression of CDH1 protein CTD PMID:22416070 NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
JBrowse link
G M Cdh1 cadherin 1 decreases expression ISO Tacrolimus results in decreased expression of CDH1 protein CTD PMID:22416070 NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
JBrowse link
G H CDH1 cadherin 1 decreases expression EXP Tacrolimus results in decreased expression of CDH1 protein CTD PMID:22416070 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
JBrowse link
G R Cdh11 cadherin 11 increases expression ISO Tacrolimus results in increased expression of CDH11 mRNA CTD PMID:29362864 NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
JBrowse link
G M Cdh11 cadherin 11 increases expression EXP Tacrolimus results in increased expression of CDH11 mRNA CTD PMID:29362864 NCBI chr 8:103,358,727...103,512,125
Ensembl chr 8:103,358,727...103,512,274
JBrowse link
G H CDH11 cadherin 11 increases expression ISO Tacrolimus results in increased expression of CDH11 mRNA CTD PMID:29362864 NCBI chr16:64,943,753...65,123,744
Ensembl chr16:64,943,753...65,126,112
JBrowse link
G R Cdh16 cadherin 16 decreases expression ISO Tacrolimus results in decreased expression of CDH16 mRNA CTD PMID:22416070 NCBI chr19:360,824...371,008
Ensembl chr19:360,824...371,007
JBrowse link
G M Cdh16 cadherin 16 decreases expression EXP Tacrolimus results in decreased expression of CDH16 mRNA CTD PMID:22416070 NCBI chr 8:105,328,547...105,351,028
Ensembl chr 8:105,328,543...105,351,028
JBrowse link
G H CDH16 cadherin 16 decreases expression ISO Tacrolimus results in decreased expression of CDH16 mRNA CTD PMID:22416070 NCBI chr16:66,908,122...66,918,885
Ensembl chr16:66,908,122...66,918,917
JBrowse link
G R Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression EXP Tacrolimus results in increased expression of CDKN1B mRNA CTD PMID:21865292 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
JBrowse link
G M Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression ISO Tacrolimus results in increased expression of CDKN1B mRNA CTD PMID:21865292 NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
JBrowse link
G H CDKN1B cyclin dependent kinase inhibitor 1B increases expression ISO Tacrolimus results in increased expression of CDKN1B mRNA CTD PMID:21865292 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
JBrowse link
G R Cebpa CCAAT/enhancer binding protein alpha increases expression ISO Tacrolimus results in increased expression of CEBPA mRNA CTD PMID:29362864 NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
JBrowse link
G M Cebpa CCAAT/enhancer binding protein (C/EBP), alpha increases expression EXP Tacrolimus results in increased expression of CEBPA mRNA CTD PMID:29362864 NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
JBrowse link
G H CEBPA CCAAT enhancer binding protein alpha increases expression ISO Tacrolimus results in increased expression of CEBPA mRNA CTD PMID:29362864 NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
JBrowse link
G R Cenpw centromere protein W increases expression ISO Tacrolimus results in increased expression of CENPW mRNA CTD PMID:29362864 NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
JBrowse link
G M Cenpw centromere protein W increases expression EXP Tacrolimus results in increased expression of CENPW mRNA CTD PMID:29362864 NCBI chr10:30,072,005...30,076,599
Ensembl chr10:30,070,565...30,076,556
JBrowse link
G H CENPW centromere protein W increases expression ISO Tacrolimus results in increased expression of CENPW mRNA CTD PMID:29362864 NCBI chr 6:126,340,115...126,483,320
Ensembl chr 6:126,340,115...126,348,875
JBrowse link
G R Cfi complement factor I increases expression EXP Tacrolimus results in increased expression of CFI mRNA CTD PMID:21865292 NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
JBrowse link
G M Cfi complement component factor i increases expression ISO Tacrolimus results in increased expression of CFI mRNA CTD PMID:21865292 NCBI chr 3:129,630,376...129,668,981
Ensembl chr 3:129,629,533...129,668,981
JBrowse link
G H CFI complement factor I increases expression ISO Tacrolimus results in increased expression of CFI mRNA CTD PMID:21865292 NCBI chr 4:109,730,982...109,801,999
Ensembl chr 4:109,731,008...109,802,150
JBrowse link
G R Ckap2 cytoskeleton associated protein 2 increases expression ISO Tacrolimus results in increased expression of CKAP2 mRNA CTD PMID:29362864 NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
JBrowse link
G M Ckap2 cytoskeleton associated protein 2 increases expression EXP Tacrolimus results in increased expression of CKAP2 mRNA CTD PMID:29362864 NCBI chr 8:22,658,168...22,675,835
Ensembl chr 8:22,658,176...22,675,835
JBrowse link
G H CKAP2 cytoskeleton associated protein 2 increases expression ISO Tacrolimus results in increased expression of CKAP2 mRNA CTD PMID:29362864 NCBI chr13:52,455,478...52,476,627
Ensembl chr13:52,455,429...52,476,628
JBrowse link
G R Ckap4 cytoskeleton-associated protein 4 increases expression EXP Tacrolimus results in increased expression of CKAP4 mRNA CTD PMID:21865292 NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914
JBrowse link
G M Ckap4 cytoskeleton-associated protein 4 increases expression ISO Tacrolimus results in increased expression of CKAP4 mRNA CTD PMID:21865292 NCBI chr10:84,362,169...84,369,752
Ensembl chr10:84,362,169...84,369,926
JBrowse link
G H CKAP4 cytoskeleton associated protein 4 increases expression ISO Tacrolimus results in increased expression of CKAP4 mRNA CTD PMID:21865292 NCBI chr12:106,237,881...106,248,020
Ensembl chr12:106,237,881...106,304,279
JBrowse link
G R Cldn1 claudin 1 decreases expression ISO Tacrolimus results in decreased expression of CLDN1 mRNA CTD PMID:22416070 NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
JBrowse link
G M Cldn1 claudin 1 decreases expression EXP Tacrolimus results in decreased expression of CLDN1 mRNA CTD PMID:22416070 NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
JBrowse link
G H CLDN1 claudin 1 decreases expression ISO Tacrolimus results in decreased expression of CLDN1 mRNA CTD PMID:22416070 NCBI chr 3:190,305,707...190,322,446
Ensembl chr 3:190,305,707...190,322,446
JBrowse link
G R Cldn4 claudin 4 increases expression EXP Tacrolimus results in increased expression of CLDN4 mRNA CTD PMID:21865292 NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
JBrowse link
G M Cldn4 claudin 4 increases expression ISO Tacrolimus results in increased expression of CLDN4 mRNA CTD PMID:21865292 NCBI chr 5:134,973,977...134,975,788
Ensembl chr 5:134,973,973...134,975,788
JBrowse link
G H CLDN4 claudin 4 increases expression ISO Tacrolimus results in increased expression of CLDN4 mRNA CTD PMID:21865292 NCBI chr 7:73,830,996...73,832,690
Ensembl chr 7:73,799,542...73,832,690
JBrowse link
G R Cldn7 claudin 7 increases expression EXP Tacrolimus results in increased expression of CLDN7 mRNA CTD PMID:21865292 NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
JBrowse link
G M Cldn7 claudin 7 increases expression ISO Tacrolimus results in increased expression of CLDN7 mRNA CTD PMID:21865292 NCBI chr11:69,855,605...69,858,712
Ensembl chr11:69,855,605...69,858,711
JBrowse link
G H CLDN7 claudin 7 increases expression ISO Tacrolimus results in increased expression of CLDN7 mRNA CTD PMID:21865292 NCBI chr17:7,259,903...7,263,213
Ensembl chr17:7,259,903...7,263,983
JBrowse link
G R Clec7a C-type lectin domain containing 7A increases expression ISO Tacrolimus results in increased expression of CLEC7A mRNA CTD PMID:29362864 NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
JBrowse link
G M Clec7a C-type lectin domain family 7, member a increases expression EXP Tacrolimus results in increased expression of CLEC7A mRNA CTD PMID:29362864 NCBI chr 6:129,438,554...129,449,748
Ensembl chr 6:129,438,554...129,449,742
JBrowse link
G H CLEC7A C-type lectin domain containing 7A increases expression ISO Tacrolimus results in increased expression of CLEC7A mRNA CTD PMID:29362864 NCBI chr12:10,116,777...10,130,304
Ensembl chr12:10,116,777...10,130,258
JBrowse link
G R Clk3 CDC-like kinase 3 increases expression ISO Tacrolimus results in increased expression of CLK3 mRNA CTD PMID:25270620 NCBI chr 8:58,152,155...58,167,196
Ensembl chr 8:58,152,155...58,168,181
JBrowse link
G M Clk3 CDC-like kinase 3 increases expression EXP Tacrolimus results in increased expression of CLK3 mRNA CTD PMID:25270620 NCBI chr 9:57,657,904...57,673,518
Ensembl chr 9:57,657,907...57,673,143
JBrowse link
G H CLK3 CDC like kinase 3 increases expression ISO Tacrolimus results in increased expression of CLK3 mRNA CTD PMID:25270620 NCBI chr15:74,608,372...74,630,201
Ensembl chr15:74,598,500...74,645,414
JBrowse link
G R Clu clusterin increases expression EXP Tacrolimus results in increased expression of CLU mRNA CTD PMID:21865292 NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
JBrowse link
G M Clu clusterin increases expression ISO Tacrolimus results in increased expression of CLU mRNA CTD PMID:21865292 NCBI chr14:66,205,932...66,218,997
Ensembl chr14:66,205,932...66,218,996
JBrowse link
G H CLU clusterin increases expression ISO Tacrolimus results in increased expression of CLU mRNA CTD PMID:21865292 NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
JBrowse link
G R Coch cochlin increases expression ISO Tacrolimus results in increased expression of COCH mRNA CTD PMID:25270620 NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
JBrowse link
G M Coch cochlin increases expression EXP Tacrolimus results in increased expression of COCH mRNA CTD PMID:25270620 NCBI chr12:51,640,067...51,652,556
Ensembl chr12:51,640,124...51,652,554
JBrowse link
G H COCH cochlin increases expression ISO Tacrolimus results in increased expression of COCH mRNA CTD PMID:25270620 NCBI chr14:30,874,559...30,895,615
Ensembl chr14:30,874,514...30,895,065
JBrowse link
G R Col1a1 collagen type I alpha 1 chain increases expression ISO Tacrolimus results in increased expression of COL1A1 mRNA CTD PMID:29362864 NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
JBrowse link
G M Col1a1 collagen, type I, alpha 1 increases expression ISO
EXP
Tacrolimus results in increased expression of COL1A1 mRNA CTD PMID:29362864 NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
JBrowse link
G H COL1A1 collagen type I alpha 1 chain increases expression ISO
EXP
Tacrolimus results in increased expression of COL1A1 mRNA CTD PMID:29362864 NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
JBrowse link
G R Col1a2 collagen type I alpha 2 chain increases expression ISO Tacrolimus results in increased expression of COL1A2 mRNA CTD PMID:29362864 NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
JBrowse link
G M Col1a2 collagen, type I, alpha 2 increases expression EXP Tacrolimus results in increased expression of COL1A2 mRNA CTD PMID:29362864 NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
JBrowse link
G H COL1A2 collagen type I alpha 2 chain increases expression ISO Tacrolimus results in increased expression of COL1A2 mRNA CTD PMID:29362864 NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
JBrowse link
G R Col3a1 collagen type III alpha 1 chain increases expression ISO Tacrolimus results in increased expression of COL3A1 mRNA CTD PMID:29362864 NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
JBrowse link
G M Col3a1 collagen, type III, alpha 1 increases expression EXP Tacrolimus results in increased expression of COL3A1 mRNA CTD PMID:29362864 NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
JBrowse link
G H COL3A1 collagen type III alpha 1 chain increases expression ISO Tacrolimus results in increased expression of COL3A1 mRNA CTD PMID:29362864 NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
JBrowse link
G R Cops8 COP9 signalosome subunit 8 increases expression ISO Tacrolimus results in increased expression of COPS8 mRNA CTD PMID:25270620 NCBI chr 9:91,207,427...91,217,258
Ensembl chr 9:91,207,395...91,217,258
JBrowse link
G M Cops8 COP9 signalosome subunit 8 increases expression EXP Tacrolimus results in increased expression of COPS8 mRNA CTD PMID:25270620 NCBI chr 1:90,531,147...90,541,063
Ensembl chr 1:90,530,703...90,541,063
JBrowse link
G H COPS8 COP9 signalosome subunit 8 increases expression ISO Tacrolimus results in increased expression of COPS8 mRNA CTD PMID:25270620 NCBI chr 2:237,085,889...237,100,474
Ensembl chr 2:237,085,882...237,100,474
JBrowse link
G R Cp ceruloplasmin increases expression EXP Tacrolimus results in increased expression of CP mRNA CTD PMID:21865292 NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
JBrowse link
G M Cp ceruloplasmin increases expression ISO Tacrolimus results in increased expression of CP mRNA CTD PMID:21865292 NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
JBrowse link
G H CP ceruloplasmin increases expression ISO Tacrolimus results in increased expression of CP mRNA CTD PMID:21865292 NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
JBrowse link
G R Creb3l3 cAMP responsive element binding protein 3-like 3 decreases expression ISO Tacrolimus results in decreased expression of CREB3L3 mRNA CTD PMID:25270620 NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
JBrowse link
G M Creb3l3 cAMP responsive element binding protein 3-like 3 decreases expression EXP Tacrolimus results in decreased expression of CREB3L3 mRNA CTD PMID:25270620 NCBI chr10:80,920,163...80,934,706
Ensembl chr10:80,920,158...80,934,708
JBrowse link
G H CREB3L3 cAMP responsive element binding protein 3 like 3 decreases expression ISO Tacrolimus results in decreased expression of CREB3L3 mRNA CTD PMID:25270620 NCBI chr19:4,153,631...4,173,054
Ensembl chr19:4,153,631...4,173,054
JBrowse link
G R Creld2 cysteine-rich with EGF-like domains 2 increases expression ISO Tacrolimus results in increased expression of CRELD2 mRNA CTD PMID:25270620 NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
JBrowse link
G M Creld2 cysteine-rich with EGF-like domains 2 increases expression EXP Tacrolimus results in increased expression of CRELD2 mRNA CTD PMID:25270620 NCBI chr15:88,703,849...88,710,884
Ensembl chr15:88,703,849...88,710,886
JBrowse link
G H CRELD2 cysteine rich with EGF like domains 2 increases expression ISO Tacrolimus results in increased expression of CRELD2 mRNA CTD PMID:25270620 NCBI chr22:49,918,634...49,927,537
Ensembl chr22:49,918,167...49,927,540
JBrowse link
G R Csf1 colony stimulating factor 1 increases expression ISO Tacrolimus results in increased expression of CSF1 mRNA CTD PMID:23958496 NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
JBrowse link
G M Csf1 colony stimulating factor 1 (macrophage) increases expression EXP Tacrolimus results in increased expression of CSF1 mRNA CTD PMID:23958496 NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
JBrowse link
G H CSF1 colony stimulating factor 1 increases expression ISO Tacrolimus results in increased expression of CSF1 mRNA CTD PMID:23958496 NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
JBrowse link
G R Csf2 colony stimulating factor 2 decreases expression
increases expression
multiple interactions
ISO Tacrolimus results in decreased expression of CSF2 protein
Tacrolimus results in increased expression of CSF2 mRNA
Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein]
CTD PMID:1376361 PMID:11407316 PMID:23958496 NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
JBrowse link
G M Csf2 colony stimulating factor 2 (granulocyte-macrophage) decreases expression
increases expression
multiple interactions
ISO
EXP
Tacrolimus results in decreased expression of CSF2 protein
Tacrolimus results in increased expression of CSF2 mRNA
Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein]
CTD PMID:1376361 PMID:11407316 PMID:23958496 NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
JBrowse link
G H CSF2 colony stimulating factor 2 decreases expression
increases expression
multiple interactions
EXP
ISO
Tacrolimus results in decreased expression of CSF2 protein
Tacrolimus results in increased expression of CSF2 mRNA
Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein]
CTD PMID:1376361 PMID:11407316 PMID:23958496 NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
JBrowse link
G R Csf2rb colony stimulating factor 2 receptor subunit beta increases expression ISO Tacrolimus results in increased expression of CSF2RB2 mRNA CTD PMID:29362864 NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157
JBrowse link
G H CSF2RB colony stimulating factor 2 receptor subunit beta increases expression ISO Tacrolimus results in increased expression of CSF2RB2 mRNA CTD PMID:29362864 NCBI chr22:36,913,628...36,940,439
Ensembl chr22:36,913,628...36,940,439
JBrowse link
G M Csf2rb2 colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage) increases expression EXP Tacrolimus results in increased expression of CSF2RB2 mRNA CTD PMID:29362864 NCBI chr15:78,166,707...78,189,921
Ensembl chr15:78,166,707...78,189,921
JBrowse link
G R Ctsl cathepsin L multiple interactions
increases expression
ISO
EXP
Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CTSL protein]
Tacrolimus results in increased expression of CTSL mRNA
CTD PMID:18172886 PMID:21865292 PMID:25270620 NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
JBrowse link
G M Ctsl cathepsin L multiple interactions
increases expression
EXP
ISO
Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CTSL protein]
Tacrolimus results in increased expression of CTSL mRNA
CTD PMID:18172886 PMID:21865292 PMID:25270620 NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704
JBrowse link
G H CTSL cathepsin L multiple interactions
increases expression
ISO Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CTSL protein]
Tacrolimus results in increased expression of CTSL mRNA
CTD PMID:18172886 PMID:21865292 PMID:25270620 NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
JBrowse link
G R Cxcl10 C-X-C motif chemokine ligand 10 increases expression EXP
ISO
Tacrolimus results in increased expression of CXCL10 mRNA CTD PMID:21865292 PMID:23958496 PMID:25270620 NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
JBrowse link
G M Cxcl10 chemokine (C-X-C motif) ligand 10 increases expression ISO
EXP
Tacrolimus results in increased expression of CXCL10 mRNA CTD PMID:21865292 PMID:23958496 PMID:25270620 NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
JBrowse link
G H CXCL10 C-X-C motif chemokine ligand 10 increases expression ISO Tacrolimus results in increased expression of CXCL10 mRNA CTD PMID:21865292 PMID:23958496 PMID:25270620 NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
JBrowse link
G R Cxcl11 C-X-C motif chemokine ligand 11 increases expression ISO Tacrolimus results in increased expression of CXCL11 mRNA CTD PMID:23958496 NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
JBrowse link
G M Cxcl11 chemokine (C-X-C motif) ligand 11 increases expression EXP Tacrolimus results in increased expression of CXCL11 mRNA CTD PMID:23958496 NCBI chr 5:92,507,403...92,511,155
Ensembl chr 5:92,507,403...92,513,344
JBrowse link
G H CXCL11 C-X-C motif chemokine ligand 11 increases expression ISO Tacrolimus results in increased expression of CXCL11 mRNA CTD PMID:23958496 NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
JBrowse link
G M Cxcl15 chemokine (C-X-C motif) ligand 15 multiple interactions ISO Tacrolimus inhibits the reaction [cinnamaldehyde results in increased expression of CXCL8 mRNA]; Tacrolimus inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CXCL8 mRNA] CTD PMID:20090409 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G H CXCL8 C-X-C motif chemokine ligand 8 multiple interactions EXP Tacrolimus inhibits the reaction [cinnamaldehyde results in increased expression of CXCL8 mRNA]; Tacrolimus inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CXCL8 mRNA] CTD PMID:20090409 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
JBrowse link
G R Cyba cytochrome b-245 alpha chain multiple interactions
increases expression
ISO Ramipril inhibits the reaction [Tacrolimus results in increased expression of CYBA mRNA] CTD PMID:12352326 NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
JBrowse link
G M Cyba cytochrome b-245, alpha polypeptide multiple interactions
increases expression
ISO Ramipril inhibits the reaction [Tacrolimus results in increased expression of CYBA mRNA] CTD PMID:12352326 NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
JBrowse link
G H CYBA cytochrome b-245 alpha chain multiple interactions
increases expression
EXP Ramipril inhibits the reaction [Tacrolimus results in increased expression of CYBA mRNA] CTD PMID:12352326 NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
JBrowse link
G R Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 increases expression EXP Tacrolimus results in increased expression of CYP27B1 mRNA CTD PMID:21865292 NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
JBrowse link
G M Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 increases expression ISO Tacrolimus results in increased expression of CYP27B1 mRNA CTD PMID:21865292 NCBI chr10:126,884,115...126,891,897
Ensembl chr10:126,884,119...126,888,875
JBrowse link
G H CYP27B1 cytochrome P450 family 27 subfamily B member 1 increases expression ISO Tacrolimus results in increased expression of CYP27B1 mRNA CTD PMID:21865292 NCBI chr12:57,762,334...57,767,078
Ensembl chr12:57,762,334...57,768,986
JBrowse link
G H CYP2C19 cytochrome P450 family 2 subfamily C member 19 multiple interactions EXP CYP2C19 affects the reaction [Lansoprazole affects the susceptibility to Tacrolimus]; CYP2C19 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole]; CYP2C19 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole]; CYP2C19 gene mutant form affects the susceptibility to [Lansoprazole co-treated with Tacrolimus] CTD PMID:15010519 PMID:15285851 PMID:17377957 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
JBrowse link
G M Cyp2c38 cytochrome P450, family 2, subfamily c, polypeptide 38 multiple interactions ISO CYP2C19 affects the reaction [Lansoprazole affects the susceptibility to Tacrolimus]; CYP2C19 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole]; CYP2C19 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole]; CYP2C19 gene mutant form affects the susceptibility to [Lansoprazole co-treated with Tacrolimus] CTD PMID:15010519 PMID:15285851 PMID:17377957 NCBI chr19:39,378,000...39,451,547
Ensembl chr19:39,378,000...39,451,519
JBrowse link
G R Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 multiple interactions ISO CYP2C19 affects the reaction [Lansoprazole affects the susceptibility to Tacrolimus]; CYP2C19 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole]; CYP2C19 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole]; CYP2C19 gene mutant form affects the susceptibility to [Lansoprazole co-treated with Tacrolimus] CTD PMID:15010519 PMID:15285851 PMID:17377957 NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
JBrowse link
G M Cyp3a11 cytochrome P450, family 3, subfamily a, polypeptide 11 decreases methylation
affects metabolic processing
affects response to substance
multiple interactions
ISO CYP3A5 protein results in decreased methylation of Tacrolimus
CYP3A5 gene polymorphism affects the metabolism of Tacrolimus; CYP3A5 gene SNP affects the metabolism of Tacrolimus; CYP3A5 protein affects the metabolism of Tacrolimus; CYP3A5 protein polymorphism affects the metabolism of Tacrolimus
CYP3A5 gene affects the susceptibility to Tacrolimus
CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole]; CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole]; CYP3A5 gene polymorphism affects the reaction [Ketoconazole results in decreased metabolism of Tacrolimus]
CTD PMID:15502717 PMID:15723604 PMID:15729180 PMID:15808586 PMID:15919447 More... NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
JBrowse link
G M Cyp3a13 cytochrome P450, family 3, subfamily a, polypeptide 13 decreases methylation ISO CYP3A7 protein results in decreased methylation of Tacrolimus CTD PMID:15951320 NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
JBrowse link
G R Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases metabolic processing
affects metabolic processing
decreases methylation
multiple interactions
ISO CYP3A4 protein results in increased metabolism of Tacrolimus
CYP3A4 protein affects the metabolism of Tacrolimus
CYP3A4 protein results in decreased methylation of Tacrolimus
Metronidazole inhibits the reaction [CYP3A4 protein results in increased metabolism of Tacrolimus]
CTD PMID:15010519 PMID:15855244 PMID:15919446 PMID:15951320 PMID:15964336 NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
JBrowse link
G H CYP3A4 cytochrome P450 family 3 subfamily A member 4 affects metabolic processing
decreases methylation
increases metabolic processing
multiple interactions
EXP CYP3A4 protein affects the metabolism of Tacrolimus
CYP3A4 protein results in decreased methylation of Tacrolimus
CYP3A4 protein results in increased metabolism of Tacrolimus
Metronidazole inhibits the reaction [CYP3A4 protein results in increased metabolism of Tacrolimus]
CTD PMID:15010519 PMID:15855244 PMID:15919446 PMID:15951320 PMID:15964336 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G H CYP3A5 cytochrome P450 family 3 subfamily A member 5 multiple interactions
decreases methylation
affects metabolic processing
affects response to substance
EXP CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole]; CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole]; CYP3A5 gene polymorphism affects the reaction [Ketoconazole results in decreased metabolism of Tacrolimus]
CYP3A5 protein results in decreased methylation of Tacrolimus
CYP3A5 gene polymorphism affects the metabolism of Tacrolimus; CYP3A5 gene SNP affects the metabolism of Tacrolimus; CYP3A5 protein affects the metabolism of Tacrolimus; CYP3A5 protein polymorphism affects the metabolism of Tacrolimus
CYP3A5 gene affects the susceptibility to Tacrolimus
CTD PMID:15502717 PMID:15723604 PMID:15729180 PMID:15808586 PMID:15919447 More... NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,998
JBrowse link
G H CYP3A51P cytochrome P450 family 3 subfamily A member 51, pseudogene affects metabolic processing EXP CYP3A51P gene SNP affects the metabolism of Tacrolimus CTD PMID:15729180 NCBI chr 7:99,685,024...99,700,120
Ensembl chr 7:99,685,145...99,700,034
JBrowse link
G H CYP3A7 cytochrome P450 family 3 subfamily A member 7 decreases methylation EXP CYP3A7 protein results in decreased methylation of Tacrolimus CTD PMID:15951320 NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
JBrowse link
G R Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions
decreases methylation
affects metabolic processing
affects response to substance
ISO CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole]; CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole]; CYP3A5 gene polymorphism affects the reaction [Ketoconazole results in decreased metabolism of Tacrolimus]
CYP3A5 protein results in decreased methylation of Tacrolimus
CYP3A5 gene polymorphism affects the metabolism of Tacrolimus; CYP3A5 gene SNP affects the metabolism of Tacrolimus; CYP3A5 protein affects the metabolism of Tacrolimus; CYP3A5 protein polymorphism affects the metabolism of Tacrolimus
CYP3A5 gene affects the susceptibility to Tacrolimus
CTD PMID:15502717 PMID:15723604 PMID:15729180 PMID:15808586 PMID:15919447 More... NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
JBrowse link
G R Dcn decorin increases expression ISO Tacrolimus results in increased expression of DCN mRNA CTD PMID:29362864 NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
JBrowse link
G M Dcn decorin increases expression EXP Tacrolimus results in increased expression of DCN mRNA CTD PMID:29362864 NCBI chr10:97,315,362...97,354,025
Ensembl chr10:97,315,471...97,354,005
JBrowse link
G H DCN decorin increases expression ISO Tacrolimus results in increased expression of DCN mRNA CTD PMID:29362864 NCBI chr12:91,140,484...91,182,817
Ensembl chr12:91,140,484...91,183,217
JBrowse link
G R Ddit3 DNA-damage inducible transcript 3 multiple interactions
increases expression
ISO salubrinal promotes the reaction [Tacrolimus results in increased expression of DDIT3 protein]
Tacrolimus results in increased expression of DDIT3 mRNA
CTD PMID:23958496 PMID:25270620 NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
JBrowse link
G M Ddit3 DNA-damage inducible transcript 3 multiple interactions
increases expression
EXP salubrinal promotes the reaction [Tacrolimus results in increased expression of DDIT3 protein]
Tacrolimus results in increased expression of DDIT3 mRNA
CTD PMID:23958496 PMID:25270620 NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157
JBrowse link
G H DDIT3 DNA damage inducible transcript 3 multiple interactions
increases expression
ISO salubrinal promotes the reaction [Tacrolimus results in increased expression of DDIT3 protein]
Tacrolimus results in increased expression of DDIT3 mRNA
CTD PMID:23958496 PMID:25270620 NCBI chr12:57,516,588...57,521,698
Ensembl chr12:57,516,588...57,521,737
JBrowse link
G R Ddit4l DNA-damage-inducible transcript 4-like decreases expression EXP Tacrolimus results in decreased expression of DDIT4L mRNA CTD PMID:21865292 NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
JBrowse link
G M Ddit4l DNA-damage-inducible transcript 4-like decreases expression ISO Tacrolimus results in decreased expression of DDIT4L mRNA CTD PMID:21865292 NCBI chr 3:137,329,433...137,334,093
Ensembl chr 3:137,327,373...137,334,094
JBrowse link
G H DDIT4L DNA damage inducible transcript 4 like decreases expression ISO Tacrolimus results in decreased expression of DDIT4L mRNA CTD PMID:21865292 NCBI chr 4:100,185,870...100,190,468
Ensembl chr 4:100,185,870...100,190,782
JBrowse link
G R Dhcr24 24-dehydrocholesterol reductase decreases expression ISO Tacrolimus results in decreased expression of DHCR24 mRNA CTD PMID:25270620 NCBI chr 5:121,344,637...121,368,853
Ensembl chr 5:121,344,575...121,371,137
JBrowse link
G M Dhcr24 24-dehydrocholesterol reductase decreases expression EXP Tacrolimus results in decreased expression of DHCR24 mRNA CTD PMID:25270620 NCBI chr 4:106,418,235...106,446,310
Ensembl chr 4:106,418,235...106,446,310
JBrowse link
G H DHCR24 24-dehydrocholesterol reductase decreases expression ISO Tacrolimus results in decreased expression of DHCR24 mRNA CTD PMID:25270620 NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
JBrowse link
G R Dnajc30 DnaJ heat shock protein family (Hsp40) member C30 decreases expression ISO Tacrolimus results in decreased expression of DNAJC30 mRNA CTD PMID:25270620 NCBI chr12:21,628,323...21,629,389
Ensembl chr12:21,626,450...21,629,408
JBrowse link
G M Dnajc30 DnaJ heat shock protein family (Hsp40) member C30 decreases expression EXP Tacrolimus results in decreased expression of DNAJC30 mRNA CTD PMID:25270620 NCBI chr 5:135,093,060...135,094,219
Ensembl chr 5:135,093,056...135,094,716
JBrowse link
G H DNAJC30 DnaJ heat shock protein family (Hsp40) member C30 decreases expression ISO Tacrolimus results in decreased expression of DNAJC30 mRNA CTD PMID:25270620 NCBI chr 7:73,680,918...73,683,453
Ensembl chr 7:73,680,918...73,683,453
JBrowse link
G R Dnm1l dynamin 1-like multiple interactions ISO PINK1 protein affects the reaction [Tacrolimus results in increased phosphorylation of DNM1L protein]
Tacrolimus inhibits the reaction [ferric ammonium citrate results in decreased phosphorylation of DNM1L protein]
CTD PMID:19492085 PMID:26318285 NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
JBrowse link
G M Dnm1l dynamin 1-like multiple interactions ISO
EXP
PINK1 protein affects the reaction [Tacrolimus results in increased phosphorylation of DNM1L protein]
Tacrolimus inhibits the reaction [ferric ammonium citrate results in decreased phosphorylation of DNM1L protein]
CTD PMID:19492085 PMID:26318285 NCBI chr16:16,130,092...16,176,902
Ensembl chr16:16,130,094...16,176,823
JBrowse link
G H DNM1L dynamin 1 like multiple interactions EXP
ISO
PINK1 protein affects the reaction [Tacrolimus results in increased phosphorylation of DNM1L protein]
Tacrolimus inhibits the reaction [ferric ammonium citrate results in decreased phosphorylation of DNM1L protein]
CTD PMID:19492085 PMID:26318285 NCBI chr12:32,679,301...32,745,650
Ensembl chr12:32,679,200...32,745,650
JBrowse link
G R Doc2a double C2 domain alpha decreases expression ISO Tacrolimus results in decreased expression of DOC2A mRNA CTD PMID:25270620 NCBI chr 1:181,457,415...181,462,528
Ensembl chr 1:181,458,390...181,462,030
JBrowse link
G M Doc2a double C2, alpha decreases expression EXP Tacrolimus results in decreased expression of DOC2A mRNA CTD PMID:25270620 NCBI chr 7:126,446,525...126,451,877
Ensembl chr 7:126,446,588...126,451,877
JBrowse link
G H DOC2A double C2 domain alpha decreases expression ISO Tacrolimus results in decreased expression of DOC2A mRNA CTD PMID:25270620 NCBI chr16:30,005,514...30,023,228
Ensembl chr16:30,005,514...30,023,270
JBrowse link
G R Dock10 dedicator of cytokinesis 10 increases expression ISO Tacrolimus results in increased expression of DOCK10 mRNA CTD PMID:29362864 NCBI chr 9:81,843,599...82,101,540
Ensembl chr 9:81,843,604...82,101,525
JBrowse link
G M Dock10 dedicator of cytokinesis 10 increases expression EXP Tacrolimus results in increased expression of DOCK10 mRNA CTD PMID:29362864 NCBI chr 1:80,478,785...80,736,482
Ensembl chr 1:80,478,790...80,736,244
JBrowse link
G H DOCK10 dedicator of cytokinesis 10 increases expression ISO Tacrolimus results in increased expression of DOCK10 mRNA CTD PMID:29362864 NCBI chr 2:224,765,090...225,042,468
Ensembl chr 2:224,765,090...225,042,468
JBrowse link
G R Dpp4 dipeptidylpeptidase 4 increases activity
multiple interactions
EXP Tacrolimus results in increased activity of DPP4 protein
MK0626 inhibits the reaction [Tacrolimus results in increased activity of DPP4 protein]
CTD PMID:24959755 NCBI chr 3:46,962,243...47,043,870
Ensembl chr 3:46,962,243...47,043,901
JBrowse link
G M Dpp4 dipeptidylpeptidase 4 increases activity
multiple interactions
ISO Tacrolimus results in increased activity of DPP4 protein
MK0626 inhibits the reaction [Tacrolimus results in increased activity of DPP4 protein]
CTD PMID:24959755 NCBI chr 2:62,160,417...62,242,635
Ensembl chr 2:62,160,417...62,242,575
JBrowse link
G H DPP4 dipeptidyl peptidase 4 increases activity
multiple interactions
ISO Tacrolimus results in increased activity of DPP4 protein
MK0626 inhibits the reaction [Tacrolimus results in increased activity of DPP4 protein]
CTD PMID:24959755 NCBI chr 2:161,992,245...162,074,215
Ensembl chr 2:161,992,245...162,074,394
JBrowse link
G R Drd2 dopamine receptor D2 affects activity
multiple interactions
EXP Tacrolimus affects the activity of DRD2 protein
Sulpiride inhibits the reaction [Tacrolimus affects the activity of DRD2 protein]
CTD PMID:15332494 NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875
JBrowse link
G M Drd2 dopamine receptor D2 affects activity
multiple interactions
ISO Tacrolimus affects the activity of DRD2 protein
Sulpiride inhibits the reaction [Tacrolimus affects the activity of DRD2 protein]
CTD PMID:15332494 NCBI chr 9:49,251,633...49,319,477
Ensembl chr 9:49,251,927...49,319,477
JBrowse link
G H DRD2 dopamine receptor D2 affects activity
multiple interactions
ISO Tacrolimus affects the activity of DRD2 protein
Sulpiride inhibits the reaction [Tacrolimus affects the activity of DRD2 protein]
CTD PMID:15332494 NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
JBrowse link
G M Ear1 eosinophil-associated, ribonuclease A family, member 1 increases expression EXP Tacrolimus results in increased expression of EAR1 mRNA CTD PMID:29362864 NCBI chr14:44,056,222...44,057,096
Ensembl chr14:44,056,222...44,112,974
JBrowse link
G R Ech1 enoyl-CoA hydratase 1 decreases expression ISO Tacrolimus results in decreased expression of ECH1 mRNA CTD PMID:25270620 NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
JBrowse link
G M Ech1 enoyl coenzyme A hydratase 1, peroxisomal decreases expression EXP Tacrolimus results in decreased expression of ECH1 mRNA CTD PMID:25270620 NCBI chr 7:28,524,763...28,531,664
Ensembl chr 7:28,524,642...28,531,672
JBrowse link
G H ECH1 enoyl-CoA hydratase 1 decreases expression ISO Tacrolimus results in decreased expression of ECH1 mRNA CTD PMID:25270620 NCBI chr19:38,815,422...38,831,794
Ensembl chr19:38,815,422...38,831,841
JBrowse link
G R Edem1 ER degradation enhancing alpha-mannosidase like protein 1 increases expression ISO Tacrolimus results in increased expression of EDEM1 mRNA CTD PMID:25270620 NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
JBrowse link
G M Edem1 ER degradation enhancer, mannosidase alpha-like 1 increases expression EXP Tacrolimus results in increased expression of EDEM1 mRNA CTD PMID:25270620 NCBI chr 6:108,800,984...108,836,317
Ensembl chr 6:108,805,602...108,836,317
JBrowse link
G H EDEM1 ER degradation enhancing alpha-mannosidase like protein 1 increases expression ISO Tacrolimus results in increased expression of EDEM1 mRNA CTD PMID:25270620 NCBI chr 3:5,187,707...5,219,958
Ensembl chr 3:5,187,646...5,219,958
JBrowse link
G R Edn1 endothelin 1 increases expression EXP Tacrolimus results in increased expression of EDN1 mRNA; Tacrolimus results in increased expression of EDN1 protein CTD PMID:9517403 PMID:9931093 NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
JBrowse link
G M Edn1 endothelin 1 increases expression ISO Tacrolimus results in increased expression of EDN1 mRNA; Tacrolimus results in increased expression of EDN1 protein CTD PMID:9517403 PMID:9931093 NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
JBrowse link
G H EDN1 endothelin 1 increases expression ISO Tacrolimus results in increased expression of EDN1 mRNA; Tacrolimus results in increased expression of EDN1 protein CTD PMID:9517403 PMID:9931093 NCBI chr 6:12,256,484...12,297,194
Ensembl chr 6:12,290,361...12,297,194
JBrowse link
G R Ednra endothelin receptor type A increases activity
increases expression
EXP Tacrolimus results in increased activity of EDNRA protein
Tacrolimus results in increased expression of EDNRA mRNA
CTD PMID:8587392 PMID:15964565 NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
JBrowse link
G M Ednra endothelin receptor type A increases activity
increases expression
ISO Tacrolimus results in increased activity of EDNRA protein
Tacrolimus results in increased expression of EDNRA mRNA
CTD PMID:8587392 PMID:15964565 NCBI chr 8:78,389,658...78,451,081
Ensembl chr 8:78,389,660...78,451,093
JBrowse link
G H EDNRA endothelin receptor type A increases activity
increases expression
ISO Tacrolimus results in increased activity of EDNRA protein
Tacrolimus results in increased expression of EDNRA mRNA
CTD PMID:8587392 PMID:15964565 NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
JBrowse link
G R Efemp2 EGF containing fibulin extracellular matrix protein 2 increases expression ISO Tacrolimus results in increased expression of EFEMP2 mRNA CTD PMID:29362864 NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
JBrowse link
G M Efemp2 epidermal growth factor-containing fibulin-like extracellular matrix protein 2 increases expression EXP Tacrolimus results in increased expression of EFEMP2 mRNA CTD PMID:29362864 NCBI chr19:5,523,974...5,532,548
Ensembl chr19:5,523,982...5,532,545
JBrowse link
G H EFEMP2 EGF containing fibulin extracellular matrix protein 2 increases expression ISO Tacrolimus results in increased expression of EFEMP2 mRNA CTD PMID:29362864 NCBI chr11:65,866,441...65,872,800
Ensembl chr11:65,866,441...65,873,592
JBrowse link
G R Egr1 early growth response 1 increases expression EXP Tacrolimus results in increased expression of EGR1 mRNA CTD PMID:21865292 NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
JBrowse link
G M Egr1 early growth response 1 increases expression ISO Tacrolimus results in increased expression of EGR1 mRNA CTD PMID:21865292 NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
JBrowse link
G H EGR1 early growth response 1 increases expression ISO Tacrolimus results in increased expression of EGR1 mRNA CTD PMID:21865292 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
JBrowse link
G R Egr2 early growth response 2 increases expression EXP Tacrolimus results in increased expression of EGR2 mRNA CTD PMID:21865292 NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
JBrowse link
G M Egr2 early growth response 2 increases expression ISO Tacrolimus results in increased expression of EGR2 mRNA CTD PMID:21865292 NCBI chr10:67,370,334...67,383,354
Ensembl chr10:67,371,305...67,378,018
JBrowse link
G H EGR2 early growth response 2 increases expression ISO Tacrolimus results in increased expression of EGR2 mRNA CTD PMID:21865292 NCBI chr10:62,811,996...62,819,167
Ensembl chr10:62,811,996...62,819,167
JBrowse link
G R Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions ISO Tacrolimus inhibits the reaction [Sirolimus results in decreased phosphorylation of and results in increased activity of EIF4EBP1 protein] CTD PMID:8599949 NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
JBrowse link
G M Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions EXP Tacrolimus inhibits the reaction [Sirolimus results in decreased phosphorylation of and results in increased activity of EIF4EBP1 protein] CTD PMID:8599949 NCBI chr 8:27,750,355...27,765,684
Ensembl chr 8:27,750,357...27,766,702
JBrowse link
G H EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions ISO Tacrolimus inhibits the reaction [Sirolimus results in decreased phosphorylation of and results in increased activity of EIF4EBP1 protein] CTD PMID:8599949 NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
JBrowse link
G R Elac2 elaC ribonuclease Z 2 decreases expression ISO Tacrolimus results in decreased expression of ELAC2 mRNA CTD PMID:25270620 NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614
JBrowse link
G M Elac2 elaC ribonuclease Z 2 decreases expression EXP Tacrolimus results in decreased expression of ELAC2 mRNA CTD PMID:25270620 NCBI chr11:64,869,856...64,892,906
Ensembl chr11:64,869,864...64,892,895
JBrowse link
G H ELAC2 elaC ribonuclease Z 2 decreases expression ISO Tacrolimus results in decreased expression of ELAC2 mRNA CTD PMID:25270620 NCBI chr17:12,991,612...13,018,027
Ensembl chr17:12,991,612...13,018,065
JBrowse link
G R Ern1 endoplasmic reticulum to nucleus signaling 1 increases phosphorylation ISO Tacrolimus results in increased phosphorylation of ERN1 protein CTD PMID:23958496 NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
JBrowse link
G M Ern1 endoplasmic reticulum (ER) to nucleus signalling 1 increases phosphorylation EXP Tacrolimus results in increased phosphorylation of ERN1 protein CTD PMID:23958496 NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
JBrowse link
G H ERN1 endoplasmic reticulum to nucleus signaling 1 increases phosphorylation ISO Tacrolimus results in increased phosphorylation of ERN1 protein CTD PMID:23958496 NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
JBrowse link
G R Ero1a endoplasmic reticulum oxidoreductase 1 alpha increases expression ISO Tacrolimus results in increased expression of ERO1A mRNA CTD PMID:23958496 NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
JBrowse link
G M Ero1a endoplasmic reticulum oxidoreductase 1 alpha increases expression EXP Tacrolimus results in increased expression of ERO1A mRNA CTD PMID:23958496 NCBI chr14:45,520,544...45,556,029
Ensembl chr14:45,520,544...45,556,228
JBrowse link
G H ERO1A endoplasmic reticulum oxidoreductase 1 alpha increases expression ISO Tacrolimus results in increased expression of ERO1A mRNA CTD PMID:23958496 NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,695,900
JBrowse link
G R Exosc4 exosome component 4 decreases expression ISO Tacrolimus results in decreased expression of EXOSC4 mRNA CTD PMID:25270620 NCBI chr 7:108,047,831...108,050,573
Ensembl chr 7:108,047,831...108,050,573
JBrowse link
G M Exosc4 exosome component 4 decreases expression EXP Tacrolimus results in decreased expression of EXOSC4 mRNA CTD PMID:25270620 NCBI chr15:76,211,597...76,214,870
Ensembl chr15:76,211,597...76,214,877
JBrowse link
G H EXOSC4 exosome component 4 decreases expression ISO Tacrolimus results in decreased expression of EXOSC4 mRNA CTD PMID:25270620 NCBI chr 8:144,064,056...144,080,648
Ensembl chr 8:144,078,648...144,080,648
JBrowse link
G R F2r coagulation factor II (thrombin) receptor decreases expression ISO Tacrolimus results in decreased expression of F2R mRNA CTD PMID:25270620 NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
JBrowse link
G M F2r coagulation factor II (thrombin) receptor decreases expression EXP Tacrolimus results in decreased expression of F2R mRNA CTD PMID:25270620 NCBI chr13:95,738,288...95,754,974
Ensembl chr13:95,738,311...95,754,995
JBrowse link
G H F2R coagulation factor II thrombin receptor decreases expression ISO Tacrolimus results in decreased expression of F2R mRNA CTD PMID:25270620 NCBI chr 5:76,716,126...76,735,770
Ensembl chr 5:76,716,126...76,735,770
JBrowse link
G R Fabp2 fatty acid binding protein 2 decreases expression ISO Tacrolimus results in decreased expression of FABP2 mRNA CTD PMID:25270620 NCBI chr 2:211,040,032...211,044,089
Ensembl chr 2:211,040,032...211,044,089
JBrowse link
G M Fabp2 fatty acid binding protein 2, intestinal decreases expression EXP Tacrolimus results in decreased expression of FABP2 mRNA CTD PMID:25270620 NCBI chr 3:122,688,721...122,693,155
Ensembl chr 3:122,688,721...122,693,155
JBrowse link
G H FABP2 fatty acid binding protein 2 decreases expression ISO Tacrolimus results in decreased expression of FABP2 mRNA CTD PMID:25270620 NCBI chr 4:119,317,250...119,322,138
Ensembl chr 4:119,317,250...119,322,138
JBrowse link
G R Fas Fas cell surface death receptor multiple interactions ISO Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP8 protein]; Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein] CTD PMID:15548389 NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
JBrowse link
G M Fas Fas (TNF receptor superfamily member 6) multiple interactions ISO Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP8 protein]; Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein] CTD PMID:15548389 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
JBrowse link
G H FAS Fas cell surface death receptor multiple interactions EXP Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP8 protein]; Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein] CTD PMID:15548389 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
JBrowse link
G M Fasl Fas ligand (TNF superfamily, member 6) decreases secretion ISO Tacrolimus results in decreased secretion of FASLG protein CTD PMID:11692113 NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
JBrowse link
G R Faslg Fas ligand decreases secretion ISO Tacrolimus results in decreased secretion of FASLG protein CTD PMID:11692113 NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
JBrowse link
G H FASLG Fas ligand decreases secretion EXP Tacrolimus results in decreased secretion of FASLG protein CTD PMID:11692113 NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
JBrowse link
G R Fbln1 fibulin 1 increases expression EXP Tacrolimus results in increased expression of FBLN1 mRNA CTD PMID:21865292 NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
JBrowse link
G M Fbln1 fibulin 1 increases expression ISO Tacrolimus results in increased expression of FBLN1 mRNA CTD PMID:21865292 NCBI chr15:85,090,150...85,170,495
Ensembl chr15:85,090,150...85,170,736
JBrowse link
G H FBLN1 fibulin 1 increases expression ISO Tacrolimus results in increased expression of FBLN1 mRNA CTD PMID:21865292 NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135
JBrowse link
G R Fga fibrinogen alpha chain increases expression EXP Tacrolimus results in increased expression of FGA mRNA CTD PMID:21865292 NCBI chr 2:168,365,364...168,381,533
Ensembl chr 2:168,374,120...168,381,528
JBrowse link
G M Fga fibrinogen alpha chain increases expression ISO Tacrolimus results in increased expression of FGA mRNA CTD PMID:21865292 NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
JBrowse link
G H FGA fibrinogen alpha chain increases expression ISO Tacrolimus results in increased expression of FGA mRNA CTD PMID:21865292 NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,128...154,590,745
JBrowse link
G R Fgb fibrinogen beta chain increases expression EXP Tacrolimus results in increased expression of FGB mRNA CTD PMID:21865292 NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
JBrowse link
G M Fgb fibrinogen beta chain increases expression ISO Tacrolimus results in increased expression of FGB mRNA CTD PMID:21865292 NCBI chr 3:82,949,553...82,957,170
Ensembl chr 3:82,947,448...82,957,170
JBrowse link
G H FGB fibrinogen beta chain increases expression ISO Tacrolimus results in increased expression of FGB mRNA CTD PMID:21865292 NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
JBrowse link
G R Fgd2 FYVE, RhoGEF and PH domain containing 2 increases expression ISO Tacrolimus results in increased expression of FGD2 mRNA CTD PMID:29362864 NCBI chr20:7,424,795...7,441,603
Ensembl chr20:7,424,790...7,441,603
JBrowse link
G M Fgd2 FYVE, RhoGEF and PH domain containing 2 increases expression EXP Tacrolimus results in increased expression of FGD2 mRNA CTD PMID:29362864 NCBI chr17:29,579,878...29,598,509
Ensembl chr17:29,579,888...29,598,635
JBrowse link
G H FGD2 FYVE, RhoGEF and PH domain containing 2 increases expression ISO Tacrolimus results in increased expression of FGD2 mRNA CTD PMID:29362864 NCBI chr 6:37,005,655...37,029,069
Ensembl chr 6:37,005,646...37,029,069
JBrowse link
G R Fgf21 fibroblast growth factor 21 decreases expression ISO Tacrolimus results in decreased expression of FGF21 mRNA CTD PMID:25270620 NCBI chr 1:96,083,495...96,084,738
Ensembl chr 1:96,083,441...96,090,454
JBrowse link
G M Fgf21 fibroblast growth factor 21 decreases expression EXP Tacrolimus results in decreased expression of FGF21 mRNA CTD PMID:25270620 NCBI chr 7:45,263,314...45,264,914
Ensembl chr 7:45,263,310...45,264,914
JBrowse link
G H FGF21 fibroblast growth factor 21 decreases expression ISO Tacrolimus results in decreased expression of FGF21 mRNA CTD PMID:25270620 NCBI chr19:48,755,524...48,758,330
Ensembl chr19:48,755,524...48,758,333
JBrowse link
G R Fgl2 fibrinogen-like 2 increases expression EXP
ISO
Tacrolimus results in increased expression of FGL2 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
JBrowse link
G M Fgl2 fibrinogen-like protein 2 increases expression ISO
EXP
Tacrolimus results in increased expression of FGL2 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr 5:21,577,671...21,583,384
Ensembl chr 5:21,577,640...21,583,372
JBrowse link
G H FGL2 fibrinogen like 2 increases expression ISO Tacrolimus results in increased expression of FGL2 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr 7:77,193,369...77,199,819
Ensembl chr 7:77,193,369...77,199,848
JBrowse link
G R Fhl2 four and a half LIM domains 2 increases expression ISO Tacrolimus results in increased expression of FHL2 mRNA CTD PMID:29362864 NCBI chr 9:45,388,979...45,462,530
Ensembl chr 9:45,388,981...45,431,192
JBrowse link
G M Fhl2 four and a half LIM domains 2 increases expression EXP Tacrolimus results in increased expression of FHL2 mRNA CTD PMID:29362864 NCBI chr 1:43,162,231...43,237,503
Ensembl chr 1:43,162,234...43,236,144
JBrowse link
G H FHL2 four and a half LIM domains 2 increases expression ISO Tacrolimus results in increased expression of FHL2 mRNA CTD PMID:29362864 NCBI chr 2:105,357,712...105,438,529
Ensembl chr 2:105,357,712...105,438,513
JBrowse link
G R Fkbp1a FKBP prolyl isomerase 1A multiple interactions
increases expression
ISO
EXP
[Tacrolimus binds to FKBP1A protein] inhibits the reaction [Sirolimus binds to FKBP1A protein]; [Tacrolimus inhibits the reaction [FKBP1A protein binds to ACVR1B protein]] which results in decreased ubiquitination of ACVR1B protein; Tacrolimus inhibits the reaction [FKBP1A protein binds to and results in decreased activity of ACVR1B protein]; Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]]
Tacrolimus results in increased expression of FKBP1A protein
CTD PMID:10361256 PMID:11041285 PMID:16720724 NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
JBrowse link
G M Fkbp1a FK506 binding protein 1a multiple interactions
increases expression
ISO [Tacrolimus binds to FKBP1A protein] inhibits the reaction [Sirolimus binds to FKBP1A protein]; [Tacrolimus inhibits the reaction [FKBP1A protein binds to ACVR1B protein]] which results in decreased ubiquitination of ACVR1B protein; Tacrolimus inhibits the reaction [FKBP1A protein binds to and results in decreased activity of ACVR1B protein]; Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]]
Tacrolimus results in increased expression of FKBP1A protein
CTD PMID:10361256 PMID:11041285 PMID:16720724 NCBI chr 2:151,384,403...151,403,611
Ensembl chr 2:151,384,403...151,403,612
JBrowse link
G H FKBP1A FKBP prolyl isomerase 1A multiple interactions
increases expression
EXP
ISO
[Tacrolimus binds to FKBP1A protein] inhibits the reaction [Sirolimus binds to FKBP1A protein]; [Tacrolimus inhibits the reaction [FKBP1A protein binds to ACVR1B protein]] which results in decreased ubiquitination of ACVR1B protein; Tacrolimus inhibits the reaction [FKBP1A protein binds to and results in decreased activity of ACVR1B protein]; Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]]
Tacrolimus results in increased expression of FKBP1A protein
CTD PMID:10361256 PMID:11041285 PMID:16720724 NCBI chr20:1,368,978...1,393,054
Ensembl chr20:1,368,977...1,393,164
JBrowse link
G R Fkbp5 FKBP prolyl isomerase 5 multiple interactions ISO Tacrolimus inhibits the reaction [NR3C1 protein binds to FKBP5 protein] CTD PMID:15697228 NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
JBrowse link
G M Fkbp5 FK506 binding protein 5 multiple interactions EXP Tacrolimus inhibits the reaction [NR3C1 protein binds to FKBP5 protein] CTD PMID:15697228 NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
JBrowse link
G H FKBP5 FKBP prolyl isomerase 5 multiple interactions ISO Tacrolimus inhibits the reaction [NR3C1 protein binds to FKBP5 protein] CTD PMID:15697228 NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583
JBrowse link
G R Flt3 Fms related receptor tyrosine kinase 3 increases expression ISO Tacrolimus results in increased expression of FLT3 mRNA CTD PMID:29362864 NCBI chr12:7,623,658...7,699,474
Ensembl chr12:7,623,930...7,699,474
JBrowse link
G M Flt3 FMS-like tyrosine kinase 3 increases expression EXP Tacrolimus results in increased expression of FLT3 mRNA CTD PMID:29362864 NCBI chr 5:147,267,551...147,337,299
Ensembl chr 5:147,267,551...147,337,299
JBrowse link
G H FLT3 fms related receptor tyrosine kinase 3 increases expression ISO Tacrolimus results in increased expression of FLT3 mRNA CTD PMID:29362864 NCBI chr13:28,003,274...28,100,576
Ensembl chr13:28,003,274...28,100,592
JBrowse link
G R Fmo2 flavin containing dimethylaniline monoxygenase 2 increases expression ISO Tacrolimus results in increased expression of FMO2 mRNA CTD PMID:21621594 NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
JBrowse link
G M Fmo2 flavin containing monooxygenase 2 increases expression EXP Tacrolimus results in increased expression of FMO2 mRNA CTD PMID:21621594 NCBI chr 1:162,701,886...162,726,327
Ensembl chr 1:162,701,886...162,726,295
JBrowse link
G H FMO2 flavin containing dimethylaniline monoxygenase 2 increases expression ISO Tacrolimus results in increased expression of FMO2 mRNA CTD PMID:21621594 NCBI chr 1:171,185,208...171,212,686
Ensembl chr 1:171,185,249...171,212,686
JBrowse link
G R Fn1 fibronectin 1 multiple interactions
increases expression
ISO Tacrolimus inhibits the reaction [NPR1 protein affects the expression of FN1 mRNA]
Tacrolimus results in increased expression of FN1 mRNA
CTD PMID:15939815 PMID:29362864 NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
JBrowse link
G M Fn1 fibronectin 1 multiple interactions
increases expression
EXP
ISO
Tacrolimus inhibits the reaction [NPR1 protein affects the expression of FN1 mRNA]
Tacrolimus results in increased expression of FN1 mRNA
CTD PMID:15939815 PMID:29362864 NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
JBrowse link
G H FN1 fibronectin 1 multiple interactions
increases expression
ISO
EXP
Tacrolimus inhibits the reaction [NPR1 protein affects the expression of FN1 mRNA]
Tacrolimus results in increased expression of FN1 mRNA
CTD PMID:15939815 PMID:29362864 NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
JBrowse link
G R Fndc3a fibronectin type III domain containing 3a increases expression ISO Tacrolimus results in increased expression of FNDC3A mRNA CTD PMID:25270620 NCBI chr15:47,689,909...47,867,354
Ensembl chr15:47,689,919...47,866,784
JBrowse link
G M Fndc3a fibronectin type III domain containing 3A increases expression EXP Tacrolimus results in increased expression of FNDC3A mRNA CTD PMID:25270620 NCBI chr14:72,775,393...72,948,141
Ensembl chr14:72,775,386...72,947,443
JBrowse link
G H FNDC3A fibronectin type III domain containing 3A increases expression ISO Tacrolimus results in increased expression of FNDC3A mRNA CTD PMID:25270620 NCBI chr13:48,975,291...49,209,779
Ensembl chr13:48,975,912...49,209,779
JBrowse link
G R Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO Tacrolimus results in increased expression of FOS mRNA CTD PMID:23958496 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
JBrowse link
G M Fos FBJ osteosarcoma oncogene increases expression EXP Tacrolimus results in increased expression of FOS mRNA CTD PMID:23958496 NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
JBrowse link
G H FOS Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO Tacrolimus results in increased expression of FOS mRNA CTD PMID:23958496 NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
JBrowse link
G R Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression ISO Tacrolimus results in increased expression of FOSL1 mRNA CTD PMID:23958496 NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
JBrowse link
G M Fosl1 fos-like antigen 1 increases expression EXP Tacrolimus results in increased expression of FOSL1 mRNA CTD PMID:23958496 NCBI chr19:5,497,726...5,505,966
Ensembl chr19:5,497,575...5,505,974
JBrowse link
G H FOSL1 FOS like 1, AP-1 transcription factor subunit increases expression ISO Tacrolimus results in increased expression of FOSL1 mRNA CTD PMID:23958496 NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
JBrowse link
G R Gbp1 guanylate binding protein 1 decreases expression ISO Tacrolimus results in decreased expression of GBP1 mRNA CTD PMID:21621594 NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131
JBrowse link
G H GBP1 guanylate binding protein 1 decreases expression ISO Tacrolimus results in decreased expression of GBP1 mRNA CTD PMID:21621594 NCBI chr 1:89,052,319...89,065,208
Ensembl chr 1:89,051,882...89,065,360
JBrowse link
G M Gbp2b guanylate binding protein 2b decreases expression EXP Tacrolimus results in decreased expression of GBP1 mRNA CTD PMID:21621594 NCBI chr 3:142,300,577...142,324,940
Ensembl chr 3:142,300,608...142,324,940
JBrowse link
G R Gc GC, vitamin D binding protein decreases expression
increases expression
EXP
ISO
Tacrolimus results in decreased expression of GC mRNA
Tacrolimus results in increased expression of GC mRNA
CTD PMID:21865292 PMID:29362864 NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
JBrowse link
G M Gc vitamin D binding protein decreases expression
increases expression
ISO
EXP
Tacrolimus results in decreased expression of GC mRNA
Tacrolimus results in increased expression of GC mRNA
CTD PMID:21865292 PMID:29362864 NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
JBrowse link
G H GC GC vitamin D binding protein decreases expression
increases expression
ISO Tacrolimus results in decreased expression of GC mRNA
Tacrolimus results in increased expression of GC mRNA
CTD PMID:21865292 PMID:29362864 NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
JBrowse link
G R Gcg glucagon multiple interactions
decreases secretion
EXP MK0626 inhibits the reaction [Tacrolimus results in decreased secretion of GCG protein modified form] CTD PMID:24959755 NCBI chr 3:47,113,914...47,122,929
Ensembl chr 3:47,113,914...47,122,929
JBrowse link
G M Gcg glucagon multiple interactions
decreases secretion
ISO MK0626 inhibits the reaction [Tacrolimus results in decreased secretion of GCG protein modified form] CTD PMID:24959755 NCBI chr 2:62,304,874...62,313,997
Ensembl chr 2:62,304,874...62,313,994
JBrowse link
G H GCG glucagon multiple interactions
decreases secretion
ISO MK0626 inhibits the reaction [Tacrolimus results in decreased secretion of GCG protein modified form] CTD PMID:24959755 NCBI chr 2:162,142,882...162,152,247
Ensembl chr 2:162,142,882...162,152,404
JBrowse link
G R Gins2 GINS complex subunit 2 increases expression ISO Tacrolimus results in increased expression of GINS2 mRNA CTD PMID:29362864 NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
JBrowse link
G M Gins2 GINS complex subunit 2 (Psf2 homolog) increases expression EXP Tacrolimus results in increased expression of GINS2 mRNA CTD PMID:29362864 NCBI chr 8:121,308,005...121,315,814
Ensembl chr 8:121,305,372...121,316,043
JBrowse link
G H GINS2 GINS complex subunit 2 increases expression ISO Tacrolimus results in increased expression of GINS2 mRNA CTD PMID:29362864 NCBI chr16:85,676,198...85,688,954
Ensembl chr16:85,676,198...85,690,073
JBrowse link
G R Gjb1 gap junction protein, beta 1 increases expression ISO Tacrolimus results in increased expression of GJB1 mRNA CTD PMID:21621594 NCBI chr  X:66,501,848...66,509,783
Ensembl chr  X:66,501,820...66,509,925
JBrowse link
G M Gjb1 gap junction protein, beta 1 increases expression EXP Tacrolimus results in increased expression of GJB1 mRNA CTD PMID:21621594 NCBI chr  X:100,419,982...100,429,235
Ensembl chr  X:100,419,984...100,429,235
JBrowse link
G H GJB1 gap junction protein beta 1 increases expression ISO Tacrolimus results in increased expression of GJB1 mRNA CTD PMID:21621594 NCBI chr  X:71,215,239...71,225,516
Ensembl chr  X:71,212,811...71,225,516
JBrowse link
G R Gldc glycine decarboxylase decreases expression ISO Tacrolimus results in decreased expression of GLDC mRNA CTD PMID:25270620 NCBI chr 1:227,883,247...227,962,119
Ensembl chr 1:227,883,249...227,962,097
JBrowse link
G M Gldc glycine decarboxylase decreases expression EXP Tacrolimus results in decreased expression of GLDC mRNA CTD PMID:25270620 NCBI chr19:30,075,841...30,152,841
Ensembl chr19:30,075,847...30,152,829
JBrowse link
G H GLDC glycine decarboxylase decreases expression ISO Tacrolimus results in decreased expression of GLDC mRNA CTD PMID:25270620 NCBI chr 9:6,532,467...6,645,729
Ensembl chr 9:6,532,467...6,645,729
JBrowse link
G R Glp1r glucagon-like peptide 1 receptor decreases expression
multiple interactions
EXP Tacrolimus results in decreased expression of GLP1R protein
MK0626 inhibits the reaction [Tacrolimus results in decreased expression of GLP1R protein]
CTD PMID:24959755 NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241
JBrowse link
G M Glp1r glucagon-like peptide 1 receptor decreases expression
multiple interactions
ISO Tacrolimus results in decreased expression of GLP1R protein
MK0626 inhibits the reaction [Tacrolimus results in decreased expression of GLP1R protein]
CTD PMID:24959755 NCBI chr17:31,120,841...31,155,484
Ensembl chr17:31,120,791...31,159,765
JBrowse link
G H GLP1R glucagon like peptide 1 receptor decreases expression
multiple interactions
ISO Tacrolimus results in decreased expression of GLP1R protein
MK0626 inhibits the reaction [Tacrolimus results in decreased expression of GLP1R protein]
CTD PMID:24959755 NCBI chr 6:39,048,781...39,091,303
Ensembl chr 6:39,048,781...39,091,303
JBrowse link
G R Gpihbp1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 decreases expression ISO Tacrolimus results in decreased expression of GPIHBP1 mRNA CTD PMID:29362864 NCBI chr 7:107,285,584...107,288,702
Ensembl chr 7:107,285,654...107,288,702
JBrowse link
G M Gpihbp1 GPI-anchored HDL-binding protein 1 decreases expression EXP Tacrolimus results in decreased expression of GPIHBP1 mRNA CTD PMID:29362864 NCBI chr15:75,468,479...75,470,062
Ensembl chr15:75,468,477...75,471,330
JBrowse link
G H GPIHBP1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 decreases expression ISO Tacrolimus results in decreased expression of GPIHBP1 mRNA CTD PMID:29362864 NCBI chr 8:143,213,218...143,217,170
Ensembl chr 8:143,213,218...143,217,170
JBrowse link
G R Gpn2 GPN-loop GTPase 2 increases expression ISO Tacrolimus results in increased expression of GPN2 mRNA CTD PMID:25270620 NCBI chr 5:145,809,455...145,817,252
Ensembl chr 5:145,809,651...145,817,252
JBrowse link
G M Gpn2 GPN-loop GTPase 2 increases expression EXP Tacrolimus results in increased expression of GPN2 mRNA CTD PMID:25270620 NCBI chr 4:133,311,684...133,319,046
Ensembl chr 4:133,311,673...133,319,046
JBrowse link
G H GPN2 GPN-loop GTPase 2 increases expression ISO Tacrolimus results in increased expression of GPN2 mRNA CTD PMID:25270620 NCBI chr 1:26,876,132...26,890,283
Ensembl chr 1:26,876,132...26,890,283
JBrowse link
G R Gpnmb glycoprotein nmb increases expression EXP Tacrolimus results in increased expression of GPNMB mRNA CTD PMID:21865292 NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
JBrowse link
G M Gpnmb glycoprotein (transmembrane) nmb increases expression ISO Tacrolimus results in increased expression of GPNMB mRNA CTD PMID:21865292 NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
JBrowse link
G H GPNMB glycoprotein nmb increases expression ISO Tacrolimus results in increased expression of GPNMB mRNA CTD PMID:21865292 NCBI chr 7:23,246,775...23,275,108
Ensembl chr 7:23,235,967...23,275,108
JBrowse link
G R Grn granulin precursor increases expression ISO Tacrolimus results in increased expression of GRN mRNA CTD PMID:25270620 NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
JBrowse link
G M Grn granulin increases expression EXP Tacrolimus results in increased expression of GRN mRNA CTD PMID:25270620 NCBI chr11:102,321,333...102,327,635
Ensembl chr11:102,321,141...102,327,874
JBrowse link
G H GRN granulin precursor increases expression ISO Tacrolimus results in increased expression of GRN mRNA CTD PMID:25270620 NCBI chr17:44,345,302...44,353,106
Ensembl chr17:44,345,246...44,353,106
JBrowse link
G R Gsk3a glycogen synthase kinase 3 alpha multiple interactions
increases phosphorylation
ISO [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein]
Tacrolimus results in increased phosphorylation of GSK3A protein
CTD PMID:22416070 NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
JBrowse link
G M Gsk3a glycogen synthase kinase 3 alpha multiple interactions
increases phosphorylation
ISO [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein]
Tacrolimus results in increased phosphorylation of GSK3A protein
CTD PMID:22416070 NCBI chr 7:24,927,683...24,937,276
Ensembl chr 7:24,927,683...24,937,276
JBrowse link
G H GSK3A glycogen synthase kinase 3 alpha multiple interactions
increases phosphorylation
EXP [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein]
Tacrolimus results in increased phosphorylation of GSK3A protein
CTD PMID:22416070 NCBI chr19:42,230,190...42,242,602
Ensembl chr19:42,226,225...42,242,625
JBrowse link
G R Gsk3b glycogen synthase kinase 3 beta multiple interactions
increases phosphorylation
ISO [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein]
Tacrolimus results in increased phosphorylation of GSK3B protein
CTD PMID:22416070 NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
JBrowse link
G M Gsk3b glycogen synthase kinase 3 beta multiple interactions
increases phosphorylation
ISO [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein]
Tacrolimus results in increased phosphorylation of GSK3B protein
CTD PMID:22416070 NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
JBrowse link
G H GSK3B glycogen synthase kinase 3 beta multiple interactions
increases phosphorylation
EXP [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein]
Tacrolimus results in increased phosphorylation of GSK3B protein
CTD PMID:22416070 NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
JBrowse link
G R Gtpbp4 GTP binding protein 4 decreases expression EXP Tacrolimus results in decreased expression of GTPBP4 mRNA CTD PMID:21865292 NCBI chr17:61,308,033...61,328,184
Ensembl chr17:61,308,014...61,418,009
JBrowse link
G M Gtpbp4 GTP binding protein 4 decreases expression ISO Tacrolimus results in decreased expression of GTPBP4 mRNA CTD PMID:21865292 NCBI chr13:9,022,106...9,046,144
Ensembl chr13:9,016,367...9,046,119
JBrowse link
G H GTPBP4 GTP binding protein 4 decreases expression ISO Tacrolimus results in decreased expression of GTPBP4 mRNA CTD PMID:21865292 NCBI chr10:988,434...1,019,932
Ensembl chr10:988,434...1,019,932
JBrowse link
G R Guca2a guanylate cyclase activator 2A increases expression EXP Tacrolimus results in increased expression of GUCA2A mRNA CTD PMID:21865292 NCBI chr 5:133,237,177...133,239,019
Ensembl chr 5:133,237,177...133,239,018
JBrowse link
G M Guca2a guanylate cyclase activator 2a (guanylin) increases expression ISO Tacrolimus results in increased expression of GUCA2A mRNA CTD PMID:21865292 NCBI chr 4:119,494,929...119,496,662
Ensembl chr 4:119,494,901...119,496,668
JBrowse link
G H GUCA2A guanylate cyclase activator 2A increases expression ISO Tacrolimus results in increased expression of GUCA2A mRNA CTD PMID:21865292 NCBI chr 1:42,162,690...42,164,745
Ensembl chr 1:42,162,690...42,164,745
JBrowse link
G M H2ac23 H2A clustered histone 23 increases expression EXP Tacrolimus results in increased expression of H2AC23 mRNA CTD PMID:29362864 NCBI chr13:21,994,537...21,995,088
Ensembl chr13:21,994,635...21,995,114
JBrowse link
G R Hadhb hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta decreases expression ISO Tacrolimus results in decreased expression of HADHB mRNA CTD PMID:25270620 NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
JBrowse link
G M Hadhb hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta decreases expression EXP Tacrolimus results in decreased expression of HADHB mRNA CTD PMID:25270620 NCBI chr 5:30,360,251...30,389,591
Ensembl chr 5:30,360,246...30,389,591
JBrowse link
G H HADHB hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta decreases expression ISO Tacrolimus results in decreased expression of HADHB mRNA CTD PMID:25270620 NCBI chr 2:26,244,939...26,290,465
Ensembl chr 2:26,243,170...26,290,465
JBrowse link
G R Havcr1 hepatitis A virus cellular receptor 1 increases expression EXP Tacrolimus results in increased expression of HAVCR1 mRNA CTD PMID:21865292 NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
JBrowse link
G M Havcr1 hepatitis A virus cellular receptor 1 increases expression ISO Tacrolimus results in increased expression of HAVCR1 mRNA CTD PMID:21865292 NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
JBrowse link
G H HAVCR1 hepatitis A virus cellular receptor 1 increases expression ISO Tacrolimus results in increased expression of HAVCR1 mRNA CTD PMID:21865292 NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
JBrowse link
G R Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 increases expression ISO Tacrolimus results in increased expression of HERPUD1 mRNA CTD PMID:23958496 PMID:25270620 NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
JBrowse link
G M Herpud1 homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 increases expression EXP Tacrolimus results in increased expression of HERPUD1 mRNA CTD PMID:23958496 PMID:25270620 NCBI chr 8:95,113,057...95,121,999
Ensembl chr 8:95,113,066...95,122,005
JBrowse link
G H HERPUD1 homocysteine inducible ER protein with ubiquitin like domain 1 increases expression ISO Tacrolimus results in increased expression of HERPUD1 mRNA CTD PMID:23958496 PMID:25270620 NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
JBrowse link
G R Hexa hexosaminidase subunit alpha increases expression ISO Tacrolimus results in increased expression of HEXA mRNA CTD PMID:25270620 NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:59,936,660...59,962,013
JBrowse link
G M Hexa hexosaminidase A increases expression EXP Tacrolimus results in increased expression of HEXA mRNA CTD PMID:25270620 NCBI chr 9:59,446,574...59,472,392
Ensembl chr 9:59,446,823...59,472,392
JBrowse link
G H HEXA hexosaminidase subunit alpha increases expression ISO Tacrolimus results in increased expression of HEXA mRNA CTD PMID:25270620 NCBI chr15:72,340,924...72,376,014
Ensembl chr15:72,340,924...72,376,420
JBrowse link
G R Hgs hepatocyte growth factor-regulated tyrosine kinase substrate increases expression ISO Tacrolimus results in increased expression of HGS mRNA CTD PMID:29380240 NCBI chr10:105,739,617...105,757,838
Ensembl chr10:105,739,296...105,757,835
JBrowse link
G M Hgs HGF-regulated tyrosine kinase substrate increases expression ISO Tacrolimus results in increased expression of HGS mRNA CTD PMID:29380240 NCBI chr11:120,358,431...120,374,810
Ensembl chr11:120,358,461...120,374,805
JBrowse link
G H HGS hepatocyte growth factor-regulated tyrosine kinase substrate increases expression EXP Tacrolimus results in increased expression of HGS mRNA CTD PMID:29380240 NCBI chr17:81,684,011...81,702,121
Ensembl chr17:81,683,326...81,703,138
JBrowse link
G R Hk2 hexokinase 2 increases expression ISO Tacrolimus results in increased expression of HK2 mRNA CTD PMID:29362864 NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
JBrowse link
G M Hk2 hexokinase 2 increases expression EXP Tacrolimus results in increased expression of HK2 mRNA CTD PMID:29362864 NCBI chr 6:82,702,004...82,751,435
Ensembl chr 6:82,702,006...82,751,435
JBrowse link
G H HK2 hexokinase 2 increases expression ISO Tacrolimus results in increased expression of HK2 mRNA CTD PMID:29362864 NCBI chr 2:74,834,127...74,893,359
Ensembl chr 2:74,834,127...74,893,359
JBrowse link
G R Hk3 hexokinase 3 increases expression ISO Tacrolimus results in increased expression of HK3 mRNA CTD PMID:29362864 NCBI chr17:9,596,950...9,614,847
Ensembl chr17:9,599,865...9,614,863
JBrowse link
G M Hk3 hexokinase 3 increases expression EXP Tacrolimus results in increased expression of HK3 mRNA CTD PMID:29362864 NCBI chr13:55,153,798...55,169,233
Ensembl chr13:55,153,798...55,169,198
JBrowse link
G H HK3 hexokinase 3 increases expression ISO Tacrolimus results in increased expression of HK3 mRNA CTD PMID:29362864 NCBI chr 5:176,880,869...176,899,346
Ensembl chr 5:176,880,869...176,899,346
JBrowse link
G R Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 decreases expression ISO Tacrolimus results in decreased expression of HMGCS2 mRNA CTD PMID:25270620 NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
JBrowse link
G M Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 decreases expression EXP Tacrolimus results in decreased expression of HMGCS2 mRNA CTD PMID:25270620 NCBI chr 3:98,187,747...98,218,054
Ensembl chr 3:98,187,751...98,218,054
JBrowse link
G H HMGCS2 3-hydroxy-3-methylglutaryl-CoA synthase 2 decreases expression ISO Tacrolimus results in decreased expression of HMGCS2 mRNA CTD PMID:25270620 NCBI chr 1:119,747,996...119,768,932
Ensembl chr 1:119,748,002...119,768,905
JBrowse link
G R Hmox1 heme oxygenase 1 increases expression
decreases expression
multiple interactions
ISO
EXP
Tacrolimus results in increased expression of HMOX1 mRNA; Tacrolimus results in increased expression of HMOX1 protein
Tacrolimus results in decreased expression of HMOX1 protein
MK0626 inhibits the reaction [Tacrolimus results in decreased expression of HMOX1 protein]
CTD PMID:23958496 PMID:24959755 PMID:26260164 PMID:29362864 NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
JBrowse link
G M Hmox1 heme oxygenase 1 increases expression
decreases expression
multiple interactions
EXP
ISO
Tacrolimus results in increased expression of HMOX1 mRNA; Tacrolimus results in increased expression of HMOX1 protein
Tacrolimus results in decreased expression of HMOX1 protein
MK0626 inhibits the reaction [Tacrolimus results in decreased expression of HMOX1 protein]
CTD PMID:23958496 PMID:24959755 PMID:26260164 PMID:29362864 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G H HMOX1 heme oxygenase 1 increases expression
decreases expression
multiple interactions
ISO
EXP
Tacrolimus results in increased expression of HMOX1 mRNA; Tacrolimus results in increased expression of HMOX1 protein
Tacrolimus results in decreased expression of HMOX1 protein
MK0626 inhibits the reaction [Tacrolimus results in decreased expression of HMOX1 protein]
CTD PMID:23958496 PMID:24959755 PMID:26260164 PMID:29362864 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G R Hnf1b HNF1 homeobox B decreases expression ISO Tacrolimus results in decreased expression of HNF1B mRNA CTD PMID:22416070 NCBI chr10:68,735,894...68,789,888
Ensembl chr10:68,735,894...68,789,888
JBrowse link
G M Hnf1b HNF1 homeobox B decreases expression EXP Tacrolimus results in decreased expression of HNF1B mRNA CTD PMID:22416070 NCBI chr11:83,741,035...83,796,743
Ensembl chr11:83,740,889...83,796,645
JBrowse link
G H HNF1B HNF1 homeobox B decreases expression ISO Tacrolimus results in decreased expression of HNF1B mRNA CTD PMID:22416070 NCBI chr17:37,686,431...37,745,059
Ensembl chr17:37,686,431...37,745,059
JBrowse link
G R Hsdl2 hydroxysteroid dehydrogenase like 2 decreases expression ISO Tacrolimus results in decreased expression of HSDL2 mRNA CTD PMID:25270620 NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
JBrowse link
G M Hsdl2 hydroxysteroid dehydrogenase like 2 decreases expression EXP Tacrolimus results in decreased expression of HSDL2 mRNA CTD PMID:25270620 NCBI chr 4:59,581,515...59,618,694
Ensembl chr 4:59,581,563...59,618,689
JBrowse link
G H HSDL2 hydroxysteroid dehydrogenase like 2 decreases expression ISO Tacrolimus results in decreased expression of HSDL2 mRNA CTD PMID:25270620 NCBI chr 9:112,380,108...112,472,405
Ensembl chr 9:112,380,080...112,472,405
JBrowse link
G R Hspa5 heat shock protein family A (Hsp70) member 5 increases expression ISO Tacrolimus results in increased expression of HSPA5 mRNA CTD PMID:25270620 NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
JBrowse link
G M Hspa5 heat shock protein 5 increases expression EXP Tacrolimus results in increased expression of HSPA5 mRNA CTD PMID:25270620 NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
JBrowse link
G H HSPA5 heat shock protein family A (Hsp70) member 5 increases expression ISO Tacrolimus results in increased expression of HSPA5 mRNA CTD PMID:25270620 NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
JBrowse link
G R Hspa8 heat shock protein family A (Hsp70) member 8 multiple interactions
increases expression
EXP Tacrolimus inhibits the reaction [Acrylamide results in decreased expression of HSPA8 protein]
Tacrolimus results in increased expression of HSPA8 protein
CTD PMID:15081597 NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
JBrowse link
G M Hspa8 heat shock protein 8 multiple interactions
increases expression
ISO Tacrolimus inhibits the reaction [Acrylamide results in decreased expression of HSPA8 protein]
Tacrolimus results in increased expression of HSPA8 protein
CTD PMID:15081597 NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
JBrowse link
G H HSPA8 heat shock protein family A (Hsp70) member 8 multiple interactions
increases expression
ISO Tacrolimus inhibits the reaction [Acrylamide results in decreased expression of HSPA8 protein]
Tacrolimus results in increased expression of HSPA8 protein
CTD PMID:15081597 NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
JBrowse link
G R Htr1a 5-hydroxytryptamine receptor 1A decreases expression ISO Tacrolimus results in decreased expression of HTR1A protein CTD PMID:27606422 NCBI chr 2:36,694,174...36,695,442
Ensembl chr 2:36,694,174...36,695,442
JBrowse link
G M Htr1a 5-hydroxytryptamine (serotonin) receptor 1A decreases expression EXP Tacrolimus results in decreased expression of HTR1A protein CTD PMID:27606422 NCBI chr13:105,580,201...105,584,641
Ensembl chr13:105,580,147...105,584,630
JBrowse link
G H HTR1A 5-hydroxytryptamine receptor 1A decreases expression ISO Tacrolimus results in decreased expression of HTR1A protein CTD PMID:27606422 NCBI chr 5:63,957,874...63,962,445
Ensembl chr 5:63,957,874...63,962,507
JBrowse link
G R Htr1b 5-hydroxytryptamine receptor 1B decreases expression ISO Tacrolimus results in decreased expression of HTR1B protein CTD PMID:27606422 NCBI chr 8:82,513,572...82,534,892
Ensembl chr 8:82,517,360...82,534,549
JBrowse link
G M Htr1b 5-hydroxytryptamine (serotonin) receptor 1B decreases expression EXP Tacrolimus results in decreased expression of HTR1B protein CTD PMID:27606422 NCBI chr 9:81,510,344...81,515,885
Ensembl chr 9:81,510,344...81,515,881
JBrowse link
G H HTR1B 5-hydroxytryptamine receptor 1B decreases expression ISO Tacrolimus results in decreased expression of HTR1B protein CTD PMID:27606422 NCBI chr 6:77,460,924...77,463,491
Ensembl chr 6:77,460,924...77,463,491
JBrowse link
G R Icam1 intercellular adhesion molecule 1 decreases expression
increases expression
EXP
ISO
Tacrolimus results in decreased expression of ICAM1; Tacrolimus results in decreased expression of ICAM1 protein
Tacrolimus results in increased expression of ICAM1 mRNA
CTD PMID:9794552 PMID:10385251 PMID:23958496 NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
JBrowse link
G M Icam1 intercellular adhesion molecule 1 decreases expression
increases expression
ISO
EXP
Tacrolimus results in decreased expression of ICAM1; Tacrolimus results in decreased expression of ICAM1 protein
Tacrolimus results in increased expression of ICAM1 mRNA
CTD PMID:9794552 PMID:10385251 PMID:23958496 NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
JBrowse link
G H ICAM1 intercellular adhesion molecule 1 decreases expression
increases expression
ISO Tacrolimus results in decreased expression of ICAM1; Tacrolimus results in decreased expression of ICAM1 protein
Tacrolimus results in increased expression of ICAM1 mRNA
CTD PMID:9794552 PMID:10385251 PMID:23958496 NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
JBrowse link
G R Id1 inhibitor of DNA binding 1 increases expression ISO Tacrolimus results in increased expression of ID1 mRNA CTD PMID:25270620 PMID:29362864 NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
JBrowse link
G M Id1 inhibitor of DNA binding 1, HLH protein increases expression EXP Tacrolimus results in increased expression of ID1 mRNA CTD PMID:25270620 PMID:29362864 NCBI chr 2:152,578,171...152,579,330
Ensembl chr 2:152,578,171...152,579,330
JBrowse link
G H ID1 inhibitor of DNA binding 1 increases expression ISO Tacrolimus results in increased expression of ID1 mRNA CTD PMID:25270620 PMID:29362864 NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
JBrowse link
G R Id2 inhibitor of DNA binding 2 increases expression ISO Tacrolimus results in increased expression of ID2 mRNA CTD PMID:25270620 NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
JBrowse link
G M Id2 inhibitor of DNA binding 2 increases expression EXP Tacrolimus results in increased expression of ID2 mRNA CTD PMID:25270620 NCBI chr12:25,143,798...25,146,091
Ensembl chr12:25,143,798...25,147,139
JBrowse link
G H ID2 inhibitor of DNA binding 2 increases expression ISO Tacrolimus results in increased expression of ID2 mRNA CTD PMID:25270620 NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
JBrowse link
G R Id3 inhibitor of DNA binding 3 increases expression ISO Tacrolimus results in increased expression of ID3 mRNA CTD PMID:29362864 NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
JBrowse link
G M Id3 inhibitor of DNA binding 3 increases expression EXP Tacrolimus results in increased expression of ID3 mRNA CTD PMID:29362864 NCBI chr 4:135,871,133...135,872,703
Ensembl chr 4:135,870,808...135,873,066
JBrowse link
G H ID3 inhibitor of DNA binding 3 increases expression ISO Tacrolimus results in increased expression of ID3 mRNA CTD PMID:29362864 NCBI chr 1:23,557,926...23,559,501
Ensembl chr 1:23,557,926...23,559,501
JBrowse link
G R Id4 inhibitor of DNA binding 4 increases expression ISO Tacrolimus results in increased expression of ID4 mRNA CTD PMID:25270620 NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
JBrowse link
G M Id4 inhibitor of DNA binding 4 increases expression EXP Tacrolimus results in increased expression of ID4 mRNA CTD PMID:25270620 NCBI chr13:48,414,592...48,419,504
Ensembl chr13:48,414,704...48,419,502
JBrowse link
G H ID4 inhibitor of DNA binding 4 increases expression ISO Tacrolimus results in increased expression of ID4 mRNA CTD PMID:25270620 NCBI chr 6:19,837,370...19,842,197
Ensembl chr 6:19,837,370...19,842,197
JBrowse link
G R Idi1 isopentenyl-diphosphate delta isomerase 1 decreases expression ISO Tacrolimus results in decreased expression of IDI1 mRNA CTD PMID:25270620 NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
JBrowse link
G M Idi1 isopentenyl-diphosphate delta isomerase decreases expression EXP Tacrolimus results in decreased expression of IDI1 mRNA CTD PMID:25270620 NCBI chr13:8,935,642...8,942,432
Ensembl chr13:8,935,537...8,942,487
JBrowse link
G H IDI1 isopentenyl-diphosphate delta isomerase 1 decreases expression ISO Tacrolimus results in decreased expression of IDI1 mRNA CTD PMID:25270620 NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
JBrowse link
G M Ifi202b interferon activated gene 202B increases expression EXP Tacrolimus results in increased expression of IFI202B mRNA CTD PMID:29362864 NCBI chr 1:173,790,135...173,810,410
Ensembl chr 1:173,790,134...173,810,310
JBrowse link
G H IFI27L2 interferon alpha inducible protein 27 like 2 increases expression ISO Tacrolimus results in increased expression of IFI27L2A mRNA CTD PMID:29362864 NCBI chr14:94,127,781...94,129,604
Ensembl chr14:94,127,779...94,130,253
JBrowse link
G M Ifi27l2a interferon, alpha-inducible protein 27 like 2A increases expression EXP Tacrolimus results in increased expression of IFI27L2A mRNA CTD PMID:29362864 NCBI chr12:103,400,132...103,409,939
Ensembl chr12:103,408,426...103,409,939
JBrowse link
G R Ifi27l2b interferon, alpha-inducible protein 27 like 2B increases expression ISO Tacrolimus results in increased expression of IFI27L2A mRNA CTD PMID:29362864 NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360
JBrowse link
G R Ifng interferon gamma multiple interactions
decreases expression
decreases secretion
ISO
EXP
[Tacrolimus co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IFNG mRNA]
Tacrolimus results in decreased expression of IFNG protein
Tacrolimus results in decreased expression of IFNG mRNA; Tacrolimus results in decreased expression of IFNG protein
[Tacrolimus co-treated with TAK 779] results in decreased expression of IFNG protein
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TRP53 protein]
Tacrolimus results in decreased secretion of IFNG protein
CTD PMID:1371491 PMID:8986461 PMID:10205001 PMID:11407316 PMID:11692113 More... NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
JBrowse link
G M Ifng interferon gamma multiple interactions
decreases expression
decreases secretion
ISO
EXP
[Tacrolimus co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IFNG mRNA]
Tacrolimus results in decreased expression of IFNG protein
Tacrolimus results in decreased expression of IFNG mRNA; Tacrolimus results in decreased expression of IFNG protein
[Tacrolimus co-treated with TAK 779] results in decreased expression of IFNG protein
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TRP53 protein]
Tacrolimus results in decreased secretion of IFNG protein
CTD PMID:1371491 PMID:8986461 PMID:10205001 PMID:11407316 PMID:11692113 More... NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G H IFNG interferon gamma multiple interactions
decreases expression
decreases secretion
EXP
ISO
[Tacrolimus co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IFNG mRNA]
Tacrolimus results in decreased expression of IFNG protein
Tacrolimus results in decreased expression of IFNG mRNA; Tacrolimus results in decreased expression of IFNG protein
[Tacrolimus co-treated with TAK 779] results in decreased expression of IFNG protein
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TRP53 protein]
Tacrolimus results in decreased secretion of IFNG protein
CTD PMID:1371491 PMID:8986461 PMID:10205001 PMID:11407316 PMID:11692113 More... NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
JBrowse link
G R Igf1 insulin-like growth factor 1 increases response to substance EXP IGF1 protein results in increased susceptibility to Tacrolimus CTD PMID:12826230 NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
JBrowse link
G M Igf1 insulin-like growth factor 1 increases response to substance ISO IGF1 protein results in increased susceptibility to Tacrolimus CTD PMID:12826230 NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
JBrowse link
G H IGF1 insulin like growth factor 1 increases response to substance ISO IGF1 protein results in increased susceptibility to Tacrolimus CTD PMID:12826230 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
JBrowse link
G R Igfbp1 insulin-like growth factor binding protein 1 decreases expression
increases expression
EXP Tacrolimus results in decreased expression of IGFBP1 mRNA
Tacrolimus results in increased expression of IGFBP1 mRNA
CTD PMID:21865292 NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
JBrowse link
G M Igfbp1 insulin-like growth factor binding protein 1 decreases expression
increases expression
ISO Tacrolimus results in decreased expression of IGFBP1 mRNA
Tacrolimus results in increased expression of IGFBP1 mRNA
CTD PMID:21865292 NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
JBrowse link
G H IGFBP1 insulin like growth factor binding protein 1 decreases expression
increases expression
ISO Tacrolimus results in decreased expression of IGFBP1 mRNA
Tacrolimus results in increased expression of IGFBP1 mRNA
CTD PMID:21865292 NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660
JBrowse link
G R Igfbp5 insulin-like growth factor binding protein 5 increases expression EXP Tacrolimus results in increased expression of IGFBP5 mRNA CTD PMID:21865292 NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
JBrowse link
G M Igfbp5 insulin-like growth factor binding protein 5 increases expression ISO Tacrolimus results in increased expression of IGFBP5 mRNA CTD PMID:21865292 NCBI chr 1:72,897,224...72,914,024
Ensembl chr 1:72,897,091...72,914,043
JBrowse link
G H IGFBP5 insulin like growth factor binding protein 5 increases expression ISO Tacrolimus results in increased expression of IGFBP5 mRNA CTD PMID:21865292 NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
JBrowse link
G R Il15ra interleukin 15 receptor subunit alpha increases expression ISO Tacrolimus results in increased expression of IL15RA mRNA CTD PMID:23958496 NCBI chr17:66,802,300...66,831,973
Ensembl chr17:66,802,334...66,832,278
JBrowse link
G M Il15ra interleukin 15 receptor, alpha chain increases expression EXP Tacrolimus results in increased expression of IL15RA mRNA CTD PMID:23958496 NCBI chr 2:11,709,992...11,738,796
Ensembl chr 2:11,710,101...11,739,128
JBrowse link
G H IL15RA interleukin 15 receptor subunit alpha increases expression ISO Tacrolimus results in increased expression of IL15RA mRNA CTD PMID:23958496 NCBI chr10:5,948,900...5,978,741
Ensembl chr10:5,943,639...5,978,187
JBrowse link
G R Il17ra interleukin 17 receptor A increases expression ISO Tacrolimus results in increased expression of IL17RA mRNA CTD PMID:23958496 NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
JBrowse link
G M Il17ra interleukin 17 receptor A increases expression EXP Tacrolimus results in increased expression of IL17RA mRNA CTD PMID:23958496 NCBI chr 6:120,440,143...120,460,692
Ensembl chr 6:120,440,208...120,464,520
JBrowse link
G H IL17RA interleukin 17 receptor A increases expression ISO Tacrolimus results in increased expression of IL17RA mRNA CTD PMID:23958496 NCBI chr22:17,085,000...17,115,693
Ensembl chr22:17,084,954...17,115,693
JBrowse link
G R Il1b interleukin 1 beta increases expression ISO Tacrolimus results in increased expression of IL1B mRNA CTD PMID:29594315 NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
JBrowse link
G M Il1b interleukin 1 beta increases expression ISO Tacrolimus results in increased expression of IL1B mRNA CTD PMID:29594315 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G H IL1B interleukin 1 beta increases expression EXP Tacrolimus results in increased expression of IL1B mRNA CTD PMID:29594315 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G R Il1rn interleukin 1 receptor antagonist increases expression ISO Tacrolimus results in increased expression of IL1RN mRNA CTD PMID:23958496 NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
JBrowse link
G M Il1rn interleukin 1 receptor antagonist increases expression EXP Tacrolimus results in increased expression of IL1RN mRNA CTD PMID:23958496 NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
JBrowse link
G H IL1RN interleukin 1 receptor antagonist increases expression ISO Tacrolimus results in increased expression of IL1RN mRNA CTD PMID:23958496 NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
JBrowse link
G R Il2 interleukin 2 multiple interactions
decreases expression
ISO
EXP
[Tacrolimus co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [CD2 protein results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA]; Tacrolimus inhibits the reaction [Zinc Sulfate inhibits the reaction [Mitogens results in increased expression of IL2 mRNA]]
Tacrolimus results in decreased expression of IL2 mRNA; Tacrolimus results in decreased expression of IL2 protein
Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2 protein]; Tacrolimus inhibits the reaction [Sirolimus inhibits the reaction [IL2 protein results in increased phosphorylation of RPS6 protein]]
CTD PMID:1371491 PMID:1614535 PMID:1701765 PMID:1705513 PMID:8986461 More... NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
JBrowse link
G M Il2 interleukin 2 multiple interactions
decreases expression
ISO
EXP
[Tacrolimus co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [CD2 protein results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA]; Tacrolimus inhibits the reaction [Zinc Sulfate inhibits the reaction [Mitogens results in increased expression of IL2 mRNA]]
Tacrolimus results in decreased expression of IL2 mRNA; Tacrolimus results in decreased expression of IL2 protein
Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2 protein]; Tacrolimus inhibits the reaction [Sirolimus inhibits the reaction [IL2 protein results in increased phosphorylation of RPS6 protein]]
CTD PMID:1371491 PMID:1614535 PMID:1701765 PMID:1705513 PMID:8986461 More... NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
JBrowse link
G H IL2 interleukin 2 multiple interactions
decreases expression
EXP
ISO
[Tacrolimus co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [CD2 protein results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA]; Tacrolimus inhibits the reaction [Zinc Sulfate inhibits the reaction [Mitogens results in increased expression of IL2 mRNA]]
Tacrolimus results in decreased expression of IL2 mRNA; Tacrolimus results in decreased expression of IL2 protein
Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2 protein]; Tacrolimus inhibits the reaction [Sirolimus inhibits the reaction [IL2 protein results in increased phosphorylation of RPS6 protein]]
CTD PMID:1371491 PMID:1614535 PMID:1701765 PMID:1705513 PMID:8986461 More... NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
JBrowse link
G R Il23a interleukin 23 subunit alpha increases expression ISO Tacrolimus results in increased expression of IL23A mRNA CTD PMID:25270620 NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
JBrowse link
G M Il23a interleukin 23, alpha subunit p19 increases expression EXP Tacrolimus results in increased expression of IL23A mRNA CTD PMID:25270620 NCBI chr10:128,132,009...128,133,953
Ensembl chr10:128,132,008...128,134,621
JBrowse link
G H IL23A interleukin 23 subunit alpha increases expression ISO Tacrolimus results in increased expression of IL23A mRNA CTD PMID:25270620 NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
JBrowse link
G R Il2ra interleukin 2 receptor subunit alpha decreases expression ISO Tacrolimus results in decreased expression of IL2RA protein CTD PMID:1701765 NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
JBrowse link
G M Il2ra interleukin 2 receptor, alpha chain decreases expression EXP Tacrolimus results in decreased expression of IL2RA protein CTD PMID:1701765 NCBI chr 2:11,647,603...11,698,005
Ensembl chr 2:11,647,618...11,698,004
JBrowse link
G H IL2RA interleukin 2 receptor subunit alpha decreases expression ISO Tacrolimus results in decreased expression of IL2RA protein CTD PMID:1701765 NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
JBrowse link
G R Il3 interleukin 3 decreases expression
multiple interactions
ISO Tacrolimus results in decreased expression of IL3 protein
Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL3 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL3 protein]
CTD PMID:1376361 PMID:11407316 NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
JBrowse link
G M Il3 interleukin 3 decreases expression
multiple interactions
ISO
EXP
Tacrolimus results in decreased expression of IL3 protein
Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL3 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL3 protein]
CTD PMID:1376361 PMID:11407316 NCBI chr11:54,155,911...54,158,105
Ensembl chr11:54,156,129...54,158,103
JBrowse link
G H IL3 interleukin 3 decreases expression
multiple interactions
EXP
ISO
Tacrolimus results in decreased expression of IL3 protein
Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL3 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL3 protein]
CTD PMID:1376361 PMID:11407316 NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
JBrowse link
G R Il4 interleukin 4 multiple interactions
decreases expression
ISO
EXP
Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein]
Tacrolimus results in decreased expression of IL4 mRNA; Tacrolimus results in decreased expression of IL4 protein
Tacrolimus inhibits the reaction [bisphenol A promotes the reaction [NFATC3 protein binds to IL4 promoter]]; Tacrolimus inhibits the reaction [bisphenol A results in increased expression of IL4 protein]; Tacrolimus inhibits the reaction [nonylphenol promotes the reaction [NFATC3 protein binds to IL4 promoter]]; Tacrolimus inhibits the reaction [nonylphenol results in increased expression of IL4 protein]
CTD PMID:1371491 PMID:10685002 PMID:11407316 PMID:12709020 PMID:16368244 NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
JBrowse link
G M Il4 interleukin 4 multiple interactions
decreases expression
ISO
EXP
Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein]
Tacrolimus results in decreased expression of IL